<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Drospirenone</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Drospirenone">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Drospirenone</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Drospirenone</b> is a progestin medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses.<span class="mw-ref" id="cite_ref-Kuhl2005_1-4"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_7-0"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> It available both alone under the brand name <b>Slynd</b> and in combination with an estrogen under the brand name <b>Yasmin</b> among others.<span class="mw-ref" id="cite_ref-Drugs.com_7-1"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-5"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The medication is taken by mouth.<span class="mw-ref" id="cite_ref-Kuhl2005_1-5"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Drospirenone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Drospirenone.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Drospirenone.svg.png" data-file-width="512" data-file-height="416" data-file-type="drawing" height="183" width="225"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Drospirenone_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Drospirenone_molecule_ball.png" data-file-width="2560" data-file-height="1908" data-file-type="bitmap" height="168" width="225"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td>Droe-SPY-re-nown<span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td><i>Alone</i>: Slynd<br><i>With estradiol</i>: Angeliq<br><i>With ethinylestradiol</i>: Yasmin, Yasminelle, Yaz, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Dihydrospirenone; Dihydrospirorenone; 1,2-Dihydrospirorenone; MSp; SH-470; ZK-30595; LF-111; 17β-Hydroxy-6β,7β:15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21-carboxylic acid, γ-lactone</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth<span class="mw-ref" id="cite_ref-Kuhl2005_1-0"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Progestogen; Progestin; Antimineralocorticoid; Steroidal antiandrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03AC10<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03AC10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03AC10'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03AC10" class="external text external">WHO</a></span>)<span> </span><br>G03AA12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03AA12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03AA12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03AA12" class="external text external">WHO</a></span>) G03FA17<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03FA17  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03FA17'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03FA17" class="external text external">WHO</a></span>) (combinations with estrogens)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>66–85%<span class="mw-ref" id="cite_ref-Kuhl2005_1-1"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-0"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-0"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>95–97% (to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a>)<span class="mw-ref" id="cite_ref-Slynd-Label_4-0"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-2"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-1"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (mostly CYP450-independent (reduction, sulfation, and cleavage of lactone ring), some CYP3A4 contribution)<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-2"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Bachmann2009_5-0"><a href="#cite_note-Bachmann2009-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-WiesingerBerse2015_6-0"><a href="#cite_note-WiesingerBerse2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• Drospirenone acid<span class="mw-ref" id="cite_ref-Slynd-Label_4-1"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><br>• 4,5-Dihydrodrospirenone 3-sulfate<span class="mw-ref" id="cite_ref-Slynd-Label_4-2"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>25–33 hours<span class="mw-ref" id="cite_ref-Slynd-Label_4-3"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-3"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-3"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine, feces<span class="mw-ref" id="cite_ref-Slynd-Label_4-4"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(6<i>R</i>,7<i>R</i>,8<i>R</i>,9<i>S</i>,10<i>R</i>,13<i>S</i>,14<i>S</i>,15<i>S</i>,16<i>S</i>,17<i>S</i>)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimetylspiro-[17<i>H</i>-dicyclopropa[6,7:15,16]cyclopenta[<i>a</i>]phenantrene-17,2'(5'<i>H</i>)-furan]-3,5'(2<i>H</i>)-dione</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=67392-87-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=67392-87-4'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=67392-87-4" class="external text external">67392-87-4</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/68873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/68873'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/68873" class="external text external">68873</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01395  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01395'" tppabs="https://www.drugbank.ca/drugs/DB01395" class="external text external">DB01395</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.62105.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.62105.html'" tppabs="http://www.chemspider.com/Chemical-Structure.62105.html" class="external text external">62105</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=N295J34A25  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=N295J34A25'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=N295J34A25" class="external text external">N295J34A25</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D03917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D03917'" tppabs="https://www.kegg.jp/entry/D03917" class="external text external">D03917</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50838'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50838" class="external text external">CHEBI:50838</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1509  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1509'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1509" class="external text external">ChEMBL1509</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7046465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7046465'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7046465" class="external text external">DTXSID7046465</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.060.599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.060.599'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.060.599" class="external text external">100.060.599</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>24</sub><span>H</span><sub>30</sub><span>O</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">366.501</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC7O%5BC%40%40%5D6%28%5BC%40%40%5D3%28%5BC%40H%5D%28%5BC%40%40H%5D2%5BC%40%40H%5D4%5BC%40H%5D%28%2FC1%3DC%2FC%28%3DO%29CC%5BC%40%5D1%28C%29%5BC%40H%5D2CC3%29C4%29%5BC%40%40H%5D5C%5BC%40%40H%5D56%29C%29CC7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC7O%5BC%40%40%5D6%28%5BC%40%40%5D3%28%5BC%40H%5D%28%5BC%40%40H%5D2%5BC%40%40H%5D4%5BC%40H%5D%28%2FC1%3DC%2FC%28%3DO%29CC%5BC%40%5D1%28C%29%5BC%40H%5D2CC3%29C4%29%5BC%40%40H%5D5C%5BC%40%40H%5D56%29C%29CC7'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC7O%5BC%40%40%5D6%28%5BC%40%40%5D3%28%5BC%40H%5D%28%5BC%40%40H%5D2%5BC%40%40H%5D4%5BC%40H%5D%28%2FC1%3DC%2FC%28%3DO%29CC%5BC%40%5D1%28C%29%5BC%40H%5D2CC3%29C4%29%5BC%40%40H%5D5C%5BC%40%40H%5D56%29C%29CC7" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C7O[C@@]6([C@@]3([C@H]([C@@H]2[C@@H]4[C@H](/C1=C/C(=O)CC[C@]1(C)[C@H]2CC3)C4)[C@@H]5C[C@@H]56)C)CC7</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:METQSPRSQINEEU-HXCATZOESA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443713428&page2=Drospirenone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443713428&page2=Drospirenone'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443713428&page2=Drospirenone" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include acne, headache, breast tenderness, weight increase, and menstrual changes.<span class="mw-ref" id="cite_ref-Slynd-Label_4-6"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Rare side effects may include high potassium levels and blood clots, among others.<span class="mw-ref" id="cite_ref-Slynd-Label_4-7"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-pmid26598309_8-0"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Drospirenone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>.<span class="mw-ref" id="cite_ref-Kuhl2005_1-6"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It has additional antimineralocorticoid and antiandrogenic activity and no other important hormonal activity.<span class="mw-ref" id="cite_ref-Kuhl2005_1-7"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Because of its antimineralocorticoid activity and lack of undesirable off-target activity, drospirenone is said to more closely resemble bioidentical progesterone than other progestins.<span class="mw-ref" id="cite_ref-pmid11246598_9-0"><a href="#cite_note-pmid11246598-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid12659403_10-0"><a href="#cite_note-pmid12659403-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


<p>Drospirenone was patented in 1976 and introduced for medical use in 2000.<span class="mw-ref" id="cite_ref-Ravina2011_11-0"><a href="#cite_note-Ravina2011-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Fis2006_12-0"><a href="#cite_note-Fis2006-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It is available widely throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_7-2"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> The medication is sometimes referred to as a "fourth-generation" progestin.<span class="mw-ref" id="cite_ref-HatcherM.D.2007_13-0"><a href="#cite_note-HatcherM.D.2007-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-RossoZeichner2016_14-0"><a href="#cite_note-RossoZeichner2016-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-Drugs.com-Generic_15-0"><a href="#cite_note-Drugs.com-Generic-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> In 2017, a formulation of drospirenone with ethinylestradiol was the 98th most commonly prescribed medication in the United States, with more than eight million prescriptions.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Drospirenone (DRSP) is used by itself as a progestogen-only birth control pill, in combination with the estrogen ethinylestradiol (EE), with or without supplemental <a href="Folic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Folic_acid" title="Folic acid" class="mw-redirect">folic acid</a> (vitamin B<sub>9</sub>), as a combined birth control pill, and in combination with the estrogen estradiol (E2) for use in menopausal hormone therapy.<span class="mw-ref" id="cite_ref-AdisInsight-Slynd_18-0"><a href="#cite_note-AdisInsight-Slynd-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> A birth control pill with low-dose ethinylestradiol is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation).<span class="mw-ref" id="cite_ref-AdisInsight-Yaz_19-0"><a href="#cite_note-AdisInsight-Yaz-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com-EE/DRSP_20-0"><a href="#cite_note-Drugs.com-EE/DRSP-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> For use in menopausal hormone therapy, E2/DRSP is specifically approved to treat moderate to severe vasomotor symptoms (hot flashes), vaginal atrophy, and postmenopausal osteoporosis.<span class="mw-ref" id="cite_ref-AdisInsight-Angeliq_21-0"><a href="#cite_note-AdisInsight-Angeliq-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-Angeliq-Label_22-0"><a href="#cite_note-Angeliq-Label-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-pmid15495039_23-0"><a href="#cite_note-pmid15495039-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-pmid11401611_24-0"><a href="#cite_note-pmid11401611-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> The drospirenone component in this formulation is included specifically to prevent estrogen-induced endometrial hyperplasia.<span class="mw-ref" id="cite_ref-pmid16513012_25-0"><a href="#cite_note-pmid16513012-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Drospirenone has also been used in combination with an estrogen as a component of hormone therapy for transgender women.<span class="mw-ref" id="cite_ref-pmid28217493_26-0"><a href="#cite_note-pmid28217493-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-MajumderChatterjee2020_27-0"><a href="#cite_note-MajumderChatterjee2020-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Studies have found that EE/DRSP is superior to placebo in reducing premenstrual emotional and physical symptoms while also improving quality of life.<span class="mw-ref" id="cite_ref-pmid28477648_28-0"><a href="#cite_note-pmid28477648-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-pmid22336820_29-0"><a href="#cite_note-pmid22336820-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> E2/DRSP has been found to increase bone mineral density and to reduce the occurrence of bone fractures in postmenopausal women.<span class="mw-ref" id="cite_ref-pmid16203654_30-0"><a href="#cite_note-pmid16203654-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-pmid16513012_25-1"><a href="#cite_note-pmid16513012-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-pmid17364592_31-0"><a href="#cite_note-pmid17364592-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid19357298_32-0"><a href="#cite_note-pmid19357298-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> In addition, E2/DRSP has a favorable influence on <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a> and triglyceride levels and decreases blood pressure in women with high blood pressure.<span class="mw-ref" id="cite_ref-pmid17364592_31-1"><a href="#cite_note-pmid17364592-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid19357298_32-1"><a href="#cite_note-pmid19357298-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Due to its antimineralocorticoid activity, drospirenone opposes estrogen-induced salt and water retention and maintains or slightly reduces body weight.<span class="mw-ref" id="cite_ref-pmid18075844_33-0"><a href="#cite_note-pmid18075844-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Drospirenone is available in the following formulations, brand names, and indications:<span class="mw-ref" id="cite_ref-Drugs@FDA_34-0"><a href="#cite_note-Drugs@FDA-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-FDADrugSafety_35-0"><a href="#cite_note-FDADrugSafety-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<ul><li>Drospirenone 4<span>&nbsp;</span>mg (Slynd) – progestogen-only birth control pill<span class="mw-ref" id="cite_ref-AdisInsight-Slynd_18-1"><a href="#cite_note-AdisInsight-Slynd-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></li>
<li>Ethinylestradiol 30<span>&nbsp;</span>μg and drospirenone 3<span>&nbsp;</span>mg (Yasmin, Jasmine, Yarina, Ocella, Syeda, Zarah) – combined birth control pill<span class="mw-ref" id="cite_ref-Yasmin-Label_36-0"><a href="#cite_note-Yasmin-Label-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-AdisInsight-Yasmin_37-0"><a href="#cite_note-AdisInsight-Yasmin-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></li>
<li>Ethinylestradiol 30<span>&nbsp;</span>μg, drospirenone 3<span>&nbsp;</span>mg, and levomefolate calcium 0.451<span>&nbsp;</span>mg (Beyaz, Safyral) – combined birth control pill with vitamin B<sub>9</sub> supplementation, acne, PMS<span class="mw-ref" id="cite_ref-AdisInsight-Beyaz_38-0"><a href="#cite_note-AdisInsight-Beyaz-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Beyaz-Label_39-0"><a href="#cite_note-Beyaz-Label-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></li>
<li>Ethinylestradiol 20<span>&nbsp;</span>μg and drospirenone 3<span>&nbsp;</span>mg (Yaz, Yasminelle, Gianvi, Vestura, Loryna) – combined birth control pill, acne, PMS, PMDD, dysmenorrhea<span class="mw-ref" id="cite_ref-Yaz-Label_40-0"><a href="#cite_note-Yaz-Label-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-AdisInsight-Yaz_19-1"><a href="#cite_note-AdisInsight-Yaz-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></li>
<li>Estradiol 0.5 or 1<span>&nbsp;</span>mg and drospirenone 0.25 or 0.5<span>&nbsp;</span>mg (Angeliq) – menopausal hormone therapy (menopausal syndrome, postmenopausal osteoporosis)<span class="mw-ref" id="cite_ref-AdisInsight-Angeliq_21-1"><a href="#cite_note-AdisInsight-Angeliq-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></li></ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Contraindications of drospirenone include renal impairment or chronic kidney disease, adrenal insufficiency, presence or history of cervical cancer or other progestogen-sensitive cancers, benign or malignant liver tumors or hepatic impairment, undiagnosed abnormal uterine bleeding, and hyperkalemia (high potassium levels).<span class="mw-ref" id="cite_ref-Slynd-Label_4-8"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Yasmin_SPC_2013_41-0"><a href="#cite_note-Yasmin_SPC_2013-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-Yasmin_PI_2012_42-0"><a href="#cite_note-Yasmin_PI_2012-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Renal impairment, hepatic impairment, and adrenal insufficiency are contraindicated because they increase exposure to drospirenone and/or increase the risk of hyperkalemia with drospirenone.<span class="mw-ref" id="cite_ref-Slynd-Label_4-9"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Adverse effects of drospirenone alone occurring in more than 1% of women may include unscheduled menstrual bleeding (breakthrough or intracyclic) (40.3–64.4%), acne (3.8%), metrorrhagia (2.8%), headache (2.7%), breast pain (2.2%), weight gain (1.9%), dysmenorrhea (1.9%), nausea (1.8%), vaginal hemorrhage (1.7%), decreased libido (1.3%), breast tenderness (1.2%), and irregular menstruation (1.2%).<span class="mw-ref" id="cite_ref-Slynd-Label_4-10"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="High_potassium_levels">High potassium levels</h3></summary>
    
<p>Drospirenone is an antimineralocorticoid with <a href="Potassium.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium" title="Potassium">potassium</a>-sparing properties, though in most cases no increase of potassium levels is to be expected.<span class="mw-ref" id="cite_ref-Yasmin_SPC_2013_41-1"><a href="#cite_note-Yasmin_SPC_2013-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> In women with mild or moderate chronic kidney disease, or in combination with chronic daily use of other potassium-sparing medications (ACE inhibitors, angiotensin II receptor antagonists, potassium-sparing diuretics, <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a>, antimineralocorticoids, or nonsteroidal anti-inflammatory drugs), a potassium level should be checked after two weeks of use to test for hyperkalemia.<span class="mw-ref" id="cite_ref-Yasmin_SPC_2013_41-2"><a href="#cite_note-Yasmin_SPC_2013-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-Nelson_2011_43-0"><a href="#cite_note-Nelson_2011-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> Persistent hyperkalemia that required discontinuation occurred in 2 out of around 1,000 women (0.2%) with 4<span>&nbsp;</span>mg/day drospirenone alone in clinical trials.<span class="mw-ref" id="cite_ref-Slynd-Label_4-11"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Blood_clots">Blood clots</h3></summary>
    
<p>Birth control pills containing ethinylestradiol and a progestin are associated with an increased risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).<span class="mw-ref" id="cite_ref-pmid26780736_44-0"><a href="#cite_note-pmid26780736-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The incidence is about 4-fold higher on average than in women not taking a birth control pill.<span class="mw-ref" id="cite_ref-pmid26780736_44-1"><a href="#cite_note-pmid26780736-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The absolute risk of VTE with ethinylestradiol-containing birth control pills is small, in the area of 3 to 10 out of 10,000 women per year, relative to 1 to 5 out of 10,000 women per year not taking a birth control pill.<span class="mw-ref" id="cite_ref-pmid27051991_45-0"><a href="#cite_note-pmid27051991-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-FDA2018_46-0"><a href="#cite_note-FDA2018-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> The risk of VTE during pregnancy is 5 to 20 in 10,000 women per year and during the postpartum period is 40 to 65 per 10,000 women per year.<span class="mw-ref" id="cite_ref-FDA2018_46-1"><a href="#cite_note-FDA2018-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> The higher risk of VTE with combined birth control pills is thought to be due to the ethinylestradiol component, as ethinylestradiol has estrogenic effects on liver synthesis of coagulation factors which result in a procoagulatory state.<span class="mw-ref" id="cite_ref-pmid26598309_8-1"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> In contrast to ethinylestradiol-containing birth control pills, neither progestogen-only birth control nor the combination of transdermal estradiol and an oral progestin in menopausal hormone therapy is associated with an increased risk of VTE.<span class="mw-ref" id="cite_ref-pmid26598309_8-2"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid30626577_47-0"><a href="#cite_note-pmid30626577-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>

<p>Different progestins in ethinylestradiol-containing birth control pills have been associated with different risks of VTE.<span class="mw-ref" id="cite_ref-pmid26598309_8-3"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Birth control pills containing progestins such as <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">desogestrel</a>, <a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">gestodene</a>, drospirenone, and cyproterone acetate have been found to have 2- to 3-fold the risk of VTE of birth control pills containing <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a> in retrospective cohort and nested case–control observational studies.<span class="mw-ref" id="cite_ref-pmid26598309_8-4"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid27051991_45-1"><a href="#cite_note-pmid27051991-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> However, this area of research is controversial, and confounding factors may have been present in these studies.<span class="mw-ref" id="cite_ref-pmid26598309_8-5"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid27051991_45-2"><a href="#cite_note-pmid27051991-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-pmid27854556_48-0"><a href="#cite_note-pmid27854556-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Other observational studies, specifically prospective cohort and case control studies, have found no differences in risk between different progestins, including between birth control pills containing drospirenone and birth control pills containing levonorgestrel.<span class="mw-ref" id="cite_ref-pmid26598309_8-6"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid27051991_45-3"><a href="#cite_note-pmid27051991-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-pmid27854556_48-1"><a href="#cite_note-pmid27854556-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-pmid27678035_49-0"><a href="#cite_note-pmid27678035-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> These kinds of observational studies have certain advantages over the aforementioned types of studies, like better ability to control for confounding factors.<span class="mw-ref" id="cite_ref-pmid27678035_49-1"><a href="#cite_note-pmid27678035-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> Systematic reviews and meta-analyses of all of the data in the mid-to-late 2010s found that birth control pills containing cyproterone acetate, desogestrel, drospirenone, or gestodene overall were associated with a risk of VTE of about 1.3- to 2.0-fold compared to that of levonorgestrel-containing birth control pills.<span class="mw-ref" id="cite_ref-pmid29573722_50-0"><a href="#cite_note-pmid29573722-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-pmid29388678_51-0"><a href="#cite_note-pmid29388678-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-pmid27051991_45-4"><a href="#cite_note-pmid27051991-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>

<p>Androgenic progestins have been found to antagonize to some degree the effects of ethinylestradiol on coagulation.<span class="mw-ref" id="cite_ref-pmid17056444_52-0"><a href="#cite_note-pmid17056444-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid8794429_53-0"><a href="#cite_note-pmid8794429-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-pmid23384742_54-0"><a href="#cite_note-pmid23384742-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-pmid26512437_55-0"><a href="#cite_note-pmid26512437-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> As a result, more androgenic progestins, like levonorgestrel and <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>, may oppose the procoagulatory effects of ethinylestradiol and result in a lower increase in risk of VTE.<span class="mw-ref" id="cite_ref-pmid26598309_8-7"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid28712325_56-0"><a href="#cite_note-pmid28712325-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Conversely, this would be the case less or not at all with progestins that are less androgenic, like desogestrel and gestodene, as well as progestins that are antiandrogenic, like drospirenone and cyproterone acetate.<span class="mw-ref" id="cite_ref-pmid26598309_8-8"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid28712325_56-1"><a href="#cite_note-pmid28712325-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span></p>
 
<p>In the early 2010s, the FDA updated the label for birth control pills containing drospirenone and other progestins to include warnings for stopping use prior to and after surgery, and to warn that such birth control pills may have a higher risk of blood clots.<span class="mw-ref" id="cite_ref-Yasmin_PI_2012_42-1"><a href="#cite_note-Yasmin_PI_2012-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"> Risk of venous thromboembolism (VTE) with hormone therapy and birth control (QResearch/CPRD)</caption>
<tbody><tr>
<th class="unsortable">Type</th><th class="unsortable">Route</th><th class="unsortable">Medications</th><th>Odds ratio (95% <abbr>CI</abbr>)</th></tr>
<tr>
<td rowspan="14">Menopausal hormone therapy</td><td rowspan="10">Oral</td><td>Estradiol alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day</td><td>1.27 (1.16–1.39)*<br>1.22 (1.09–1.37)*<br>1.35 (1.18–1.55)*</td></tr>
<tr>
<td>Conjugated estrogens alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤0.625<span>&nbsp;</span>mg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;0.625<span>&nbsp;</span>mg/day</td><td>1.49 (1.39–1.60)*<br>1.40 (1.28–1.53)*<br>1.71 (1.51–1.93)*</td></tr>
<tr>
<td>Estradiol/medroxyprogesterone acetate</td><td>1.44 (1.09–1.89)*</td></tr>
<tr>
<td>Estradiol/dydrogesterone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day <abbr>E2</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day <abbr>E2</abbr></td><td>1.18 (0.98–1.42)<br>1.12 (0.90–1.40)<br>1.34 (0.94–1.90)</td></tr>
<tr>
<td>Estradiol/norethisterone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day <abbr>E2</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day <abbr>E2</abbr></td><td>1.68 (1.57–1.80)*<br>1.38 (1.23–1.56)*<br>1.84 (1.69–2.00)*</td></tr>
<tr>
<td>Estradiol/norgestrel or estradiol/drospirenone</td><td>1.42 (1.00–2.03)</td></tr>
<tr>
<td>Conjugated estrogens/medroxyprogesterone acetate</td><td>2.10 (1.92–2.31)*</td></tr>
<tr>
<td>Conjugated estrogens/norgestrel<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤0.625<span>&nbsp;</span>mg/day <abbr>CEEs</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;0.625<span>&nbsp;</span>mg/day <abbr>CEEs</abbr></td><td>1.73 (1.57–1.91)*<br>1.53 (1.36–1.72)*<br>2.38 (1.99–2.85)*</td></tr>
<tr>
<td>Tibolone alone</td><td>1.02 (0.90–1.15)</td></tr>
<tr>
<td><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a> alone</td><td>1.49 (1.24–1.79)*</td></tr>
<tr>
<td rowspan="3">Transdermal</td><td>Estradiol alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤50<span>&nbsp;</span>μg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;50<span>&nbsp;</span>μg/day</td><td>0.96 (0.88–1.04)<br>0.94 (0.85–1.03)<br>1.05 (0.88–1.24)</td></tr>
<tr>
<td>Conjugated estrogens alone</td><td>1.04 (0.76–1.43)</td></tr>
<tr>
<td>Estradiol/progestogen</td><td>0.88 (0.73–1.01)</td></tr>
<tr>
<td rowspan="1">Vaginal</td><td>Estradiol alone</td><td>0.84 (0.73–0.97)</td></tr>
<tr>
<td rowspan="7">Combined birth control</td><td rowspan="7">Oral</td><td>Ethinylestradiol/norethisterone</td><td>2.56 (2.15–3.06)*</td></tr>
<tr>
<td>Ethinylestradiol/levonorgestrel</td><td>2.38 (2.18–2.59)*</td></tr>
<tr>
<td>Ethinylestradiol/norgestimate</td><td>2.53 (2.17–2.96)*</td></tr>
<tr>
<td>Ethinylestradiol/desogestrel</td><td>4.28 (3.66–5.01)*</td></tr>
<tr>
<td>Ethinylestradiol/gestodene</td><td>3.64 (3.00–4.43)*</td></tr>
<tr>
<td>Ethinylestradiol/drospirenone</td><td>4.12 (3.43–4.96)*</td></tr>
<tr>
<td>Ethinylestradiol/cyproterone acetate</td><td>4.27 (3.57–5.11)*</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Nested case–control studies (2015, 2019) based on data from the QResearch and Clinical Practice Research Datalink (CPRD) databases. (2) Bioidentical progesterone was not included, but is known to be associated with no additional risk relative to estrogen alone. <b>Footnotes:</b> * = Statistically significant (<i>p</i> &lt; 0.01). <b>Sources</b>: See template.</td></tr>
</tbody></table>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Breast_cancer">Breast cancer</h3></summary>
    
<p>Drospirenone has been found to stimulate the proliferation and migration of breast cancer cells in preclinical research, similarly to certain other progestins.<span class="mw-ref" id="cite_ref-pmid19938948_57-0"><a href="#cite_note-pmid19938948-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-0"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> However, some evidence suggests that drospirenone may do this more weakly than certain other progestins, like <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>.<span class="mw-ref" id="cite_ref-pmid19938948_57-1"><a href="#cite_note-pmid19938948-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-1"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> The combination of estradiol and drospirenone has been found to increase breast density, an established risk factor for breast cancer, in postmenopausal women.<span class="mw-ref" id="cite_ref-pmid27548404_59-0"><a href="#cite_note-pmid27548404-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-pmid26357645_60-0"><a href="#cite_note-pmid26357645-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-pmid31239112_61-0"><a href="#cite_note-pmid31239112-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>

<p>Data on risk of breast cancer in women with newer progestins like drospirenone are lacking at present.<span class="mw-ref" id="cite_ref-pmid31512725_62-0"><a href="#cite_note-pmid31512725-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Progestogen-only birth control is not generally associated with a higher risk of breast cancer.<span class="mw-ref" id="cite_ref-pmid31512725_62-1"><a href="#cite_note-pmid31512725-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Conversely, combined birth control and menopausal hormone therapy with an estrogen and a progestogen are associated with higher risks of breast cancer.<span class="mw-ref" id="cite_ref-pmid31474332_63-0"><a href="#cite_note-pmid31474332-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-pmid31512725_62-2"><a href="#cite_note-pmid31512725-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-pmid23651281_64-0"><a href="#cite_note-pmid23651281-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>These have been no reports of serious adverse effects with overdose of drospirenone.<span class="mw-ref" id="cite_ref-Slynd-Label_4-12"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Symptoms that may occur in the event of an overdose may include nausea, vomiting, and vaginal bleeding.<span class="mw-ref" id="cite_ref-Slynd-Label_4-13"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> There is no antidote for overdose of drospirenone and treatment of overdose should be based on symptoms.<span class="mw-ref" id="cite_ref-Slynd-Label_4-14"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Since drospirenone has antimineralocorticoid activity, levels of <a href="Potassium.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium" title="Potassium">potassium</a> and <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> should be measured and signs of metabolic acidosis should be monitored.<span class="mw-ref" id="cite_ref-Slynd-Label_4-15"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Inhibitors and inducers of the cytochrome P450 enzyme CYP3A4 may influence the levels and efficacy of drospirenone.<span class="mw-ref" id="cite_ref-Slynd-Label_4-16"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Treatment for 10<span>&nbsp;</span>days with 200<span>&nbsp;</span>mg twice daily <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a>, a strong CYP3A4 inhibitor among other actions, has been found to result in a moderate 2.0 to 2.7-fold increase in exposure to drospirenone.<span class="mw-ref" id="cite_ref-Slynd-Label_4-17"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Drospirenone does not appear to influence the metabolism of <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a> (metabolized via CYP2C19), <a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">simvastatin</a> (metabolized via CYP3A4), or <a href="Midazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Midazolam" title="Midazolam">midazolam</a> (metabolized via CYP3A4), and likely does not influence the metabolism of other medications that are metabolized via these pathways.<span class="mw-ref" id="cite_ref-Slynd-Label_4-18"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Drospirenone may interact with <a href="Potassium.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium" title="Potassium">potassium</a>-sparing medications such as ACE inhibitors, angiotensin II receptor antagonists, potassium-sparing diuretics, potassium supplements, <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a>, antimineralocorticoids, and nonsteroidal anti-inflammatory drugs to further increase potassium levels.<span class="mw-ref" id="cite_ref-Slynd-Label_4-19"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> This may increase the risk of hyperkalemia (high potassium levels).<span class="mw-ref" id="cite_ref-Slynd-Label_4-20"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Drospirenone binds with high affinity to the progesterone receptor (PR) and mineralocorticoid receptor (MR), with lower affinity to the androgen receptor (AR), and with very low affinity to the glucocorticoid receptor (GR).<span class="mw-ref" id="cite_ref-Kuhl2005_1-8"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-0"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-FuhrmannKrattenmacher1996_66-0"><a href="#cite_note-FuhrmannKrattenmacher1996-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-1"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is an agonist of the PR and an antagonist of the MR and AR, and hence is a progestogen, antimineralocorticoid, and antiandrogen.<span class="mw-ref" id="cite_ref-Kuhl2005_1-9"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-1"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-2"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-2"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Drospirenone has no estrogenic activity and no appreciable glucocorticoid or antiglucocorticoid activity.<span class="mw-ref" id="cite_ref-Kuhl2005_1-10"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-2"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-3"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-3"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap">Relative affinities (%) of drospirenone and related steroids</caption>
<tbody><tr>
<th>Progestogen</th><th><abbr>PR</abbr></th><th><abbr>AR</abbr></th><th><abbr>ER</abbr></th><th><abbr>GR</abbr></th><th><abbr>MR</abbr></th><th><abbr>SHBG</abbr></th><th><abbr>CBG</abbr></th></tr>
<tr>
<td>Drospirenone</td><td>19–70</td><td>1–65</td><td>0–1</td><td>1–6</td><td>100–500</td><td>0</td><td>0</td></tr>
<tr>
<td>Progesterone</td><td>100</td><td>0–80</td><td>0–1</td><td>6–35</td><td>100–1000</td><td>0</td><td>0</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are percentages (%). Reference ligands (100%) were progesterone for the <abbr>PR</abbr>, <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">metribolone</a> for the <abbr>AR</abbr>, estradiol for the <abbr>ER</abbr>, <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a> for the <abbr>GR</abbr>, and <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a> for the <abbr>MR</abbr>. <b>Sources:</b> <span class="mw-ref" id="cite_ref-Krattenmacher2000_2-4"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-11"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-4"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid23954501_67-0"><a href="#cite_note-pmid23954501-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-4"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Progestogenic_activity">Progestogenic activity</h4></summary>
    
<p>Drospirenone is an agonist of the PR, the biological target of progestogens like progesterone.<span class="mw-ref" id="cite_ref-Kuhl2005_1-12"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-3"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> It has about 35% of the affinity of <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">promegestone</a> for the PR and about 19 to 70% of the affinity of progesterone for the PR.<span class="mw-ref" id="cite_ref-Kuhl2005_1-13"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-5"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-5"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Drospirenone has antigonadotropic and functional antiestrogenic effects as a result of PR activation.<span class="mw-ref" id="cite_ref-Kuhl2005_1-14"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-4"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> The ovulation-inhibiting dosage of drospirenone is 2 to 3<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-pmid30325245_68-0"><a href="#cite_note-pmid30325245-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-pmid22078182_69-0"><a href="#cite_note-pmid22078182-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-15"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2011_70-0"><a href="#cite_note-Kuhl2011-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> Inhibition of ovulation occurred in about 90% of women at a dose of 0.5 to 2<span>&nbsp;</span>mg/day and in 100% of women at a dose of 3<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-pmid14667981_71-0"><a href="#cite_note-pmid14667981-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> The total endometrial transformation dose of drospirenone is about 50<span>&nbsp;</span>mg per cycle, whereas its daily dose is 2<span>&nbsp;</span>mg for partial transformation and 4 to 6<span>&nbsp;</span>mg for full transformation.<span class="mw-ref" id="cite_ref-Kuhl2005_1-16"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid14670641_72-0"><a href="#cite_note-pmid14670641-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span><span class="mw-ref" id="cite_ref-pmid14667981_71-1"><a href="#cite_note-pmid14667981-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> The medication acts as a contraceptive by activating the PR, which suppresses the secretion of <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a>, inhibits ovulation, and alters the cervical membrane and endometrium.<span class="mw-ref" id="cite_ref-Drospirenone_73-0"><a href="#cite_note-Drospirenone-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-21"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Due to its antigonadotropic effects, drospirenone inhibits the secretion of the gonadotropins, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> (LH) and follicle-stimulating hormone (FSH), and suppresses gonadal sex hormone production, including of <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>, <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>, and <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>.<span class="mw-ref" id="cite_ref-Kuhl2005_1-17"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid31446440_74-0"><a href="#cite_note-pmid31446440-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-6"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Drospirenone alone at 4<span>&nbsp;</span>mg/day has been found to suppress estradiol levels in premenopausal women to about 40 to 80<span>&nbsp;</span>pg/mL depending on the time of the cycle.<span class="mw-ref" id="cite_ref-pmid31446440_74-1"><a href="#cite_note-pmid31446440-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> No studies of the antigonadotropic effects of drospirenone or its influence on hormone levels appear to have been conducted in men.<span class="mw-ref" id="cite_ref-CorniaAnawalt2005_75-0"><a href="#cite_note-CorniaAnawalt2005-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-pmid20933120_76-0"><a href="#cite_note-pmid20933120-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span><span class="mw-ref" id="cite_ref-NieschlagBehre2012_77-0"><a href="#cite_note-NieschlagBehre2012-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> In male cynomolgus monkeys however, 4<span>&nbsp;</span>mg/kg/day oral drospirenone strongly suppressed <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> levels.<span class="mw-ref" id="cite_ref-pmid7625729_65-5"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antimineralocorticoid_activity">Antimineralocorticoid activity</h4></summary>
    
<p>Drospirenone is an antagonist of the MR, the biological target of mineralocorticoids like <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a>, and hence is an antimineralocorticoid.<span class="mw-ref" id="cite_ref-pmid7625729_65-6"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> It has about 100 to 500% of the affinity of aldosterone for the MR and about 50 to 230% of the affinity of progesterone for the MR.<span class="mw-ref" id="cite_ref-Kuhl2005_1-18"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-7"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid23954501_67-1"><a href="#cite_note-pmid23954501-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-6"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Drospirenone is about 5.5 to 11<span>&nbsp;</span>times more potent as an antimineralocorticoid than <a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">spironolactone</a> in animals.<span class="mw-ref" id="cite_ref-pmid7625729_65-7"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid14667981_71-2"><a href="#cite_note-pmid14667981-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span><span class="mw-ref" id="cite_ref-Stanczyk2007_78-0"><a href="#cite_note-Stanczyk2007-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> Accordingly, 3 to 4<span>&nbsp;</span>mg drospirenone is said to be equivalent to about 20 to 25<span>&nbsp;</span>mg spironolactone in terms of antimineralocorticoid activity.<span class="mw-ref" id="cite_ref-SchneiderNaftolin2004_79-0"><a href="#cite_note-SchneiderNaftolin2004-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-22"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It has been said that the pharmacological profile of drospirenone more closely resembles that of progesterone than other progestins due to its antimineralocorticoid activity.<span class="mw-ref" id="cite_ref-pmid7625729_65-8"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Drospirenone is the only clinically used progestogen with prominent antimineralocorticoid activity besides progesterone.<span class="mw-ref" id="cite_ref-Kuhl2005_1-19"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> For comparison to progesterone, a 200<span>&nbsp;</span>mg dose of oral progesterone is considered to be approximately equivalent in antimineralocorticoid effect to a 25 to 50<span>&nbsp;</span>mg dose of spironolactone.<span class="mw-ref" id="cite_ref-pmid8616985_80-0"><a href="#cite_note-pmid8616985-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> Both drospirenone and progesterone are actually weak partial agonists of the MR in the absence of mineralocorticoids.<span class="mw-ref" id="cite_ref-pmid23238854_3-5"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-8"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-7"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>Due to its antimineralocorticoid activity, drospirenone increases natriuresis, decreases water retention and blood pressure, and produces compensatory increases in plasma renin activity as well as circulating levels and urinary excretion of <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a>.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-9"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Genazzani_2007_81-0"><a href="#cite_note-Genazzani_2007-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-20"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This has been shown to occur at doses of 2 to 4<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-10"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Similar effects occur during the luteal phase of the menstrual cycle due to increased progesterone levels and the resulting antagonism of the MR.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-11"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Estrogens, particularly ethinylestradiol, activate liver production of angiotensinogen and increase levels of angiotensinogen and angiotensin II, thereby activating the renin–angiotensin–aldosterone system.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-12"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-21"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> As a result, they can produce undesirable side effects including increased <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> excretion, water retention, weight gain, and increased blood pressure.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-13"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Progesterone and drospirenone counteract these undesirable effects via their antimineralocorticoid activity.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-14"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Accumulating research indicates that antimineralocorticoids like drospirenone and spironolactone may also have positive effects on adipose tissue and metabolic health.<span class="mw-ref" id="cite_ref-InfanteArmani2019_82-0"><a href="#cite_note-InfanteArmani2019-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-pmid26965204_83-0"><a href="#cite_note-pmid26965204-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antiandrogenic_activity">Antiandrogenic activity</h4></summary>
    
<p>Drospirenone is an antagonist of the AR, the biological target of androgens like <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT).<span class="mw-ref" id="cite_ref-Kuhl2005_1-22"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-15"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It has about 1 to 65% of the affinity of the synthetic anabolic steroid <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">metribolone</a> for the AR.<span class="mw-ref" id="cite_ref-Kuhl2005_1-23"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-16"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-6"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid21414337_58-8"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> The medication is more potent as an antiandrogen than <a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">spironolactone</a>, but is less potent than cyproterone acetate, with about 30% of its antiandrogenic activity in animals.<span class="mw-ref" id="cite_ref-Kuhl2005_1-24"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid15669548_84-0"><a href="#cite_note-pmid15669548-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-pmid7625729_65-9"><a href="#cite_note-pmid7625729-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid14667981_71-3"><a href="#cite_note-pmid14667981-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> Progesterone displays antiandrogenic activity in some assays similarly to drospirenone,<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-17"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> although this issue is controversial and many researchers regard progesterone as having no significant antiandrogenic activity.<span class="mw-ref" id="cite_ref-pmid23484104_85-0"><a href="#cite_note-pmid23484104-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-25"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-7"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Drospirenone shows antiandrogenic effects on the serum lipid profile, including higher HDL <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a> and triglyceride levels and lower LDL cholesterol levels, at a dose of 3<span>&nbsp;</span>mg/day in women.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-18"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The medication does not inhibit the effects of ethinylestradiol on sex hormone-binding globulin (SHBG) and serum lipids, in contrast to androgenic progestins like <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a> but similarly to other antiandrogenic progestins like cyproterone acetate.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-19"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-26"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2011_70-1"><a href="#cite_note-Kuhl2011-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> SHBG levels are significantly higher with ethinylestradiol and cyproterone acetate than with ethinylestradiol and drospirenone, owing to the more potent antiandrogenic activity of cyproterone acetate relative to drospirenone.<span class="mw-ref" id="cite_ref-Schindler2015_86-0"><a href="#cite_note-Schindler2015-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> Androgenic progestins like levonorgestrel have been found to inhibit the procoagulatory effects of estrogens like ethinylestradiol on hepatic synthesis of coagulation factors, whereas this may occur less or not at all with weakly androgenic progestins like <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">desogestrel</a> and antiandrogenic progestins like drospirenone.<span class="mw-ref" id="cite_ref-pmid26598309_8-9"><a href="#cite_note-pmid26598309-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid28712325_56-2"><a href="#cite_note-pmid28712325-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-pmid17056444_52-1"><a href="#cite_note-pmid17056444-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid8794429_53-1"><a href="#cite_note-pmid8794429-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-pmid23384742_54-1"><a href="#cite_note-pmid23384742-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-pmid26512437_55-1"><a href="#cite_note-pmid26512437-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_activity">Other activity</h4></summary>
    
<p>Drospirenone stimulates the proliferation of MCF-7 breast cancer cells <i>in vitro</i>, an action that is independent of the classical PRs and is instead mediated via the progesterone receptor membrane component-1 (PGRMC1).<span class="mw-ref" id="cite_ref-pmid23758160_87-0"><a href="#cite_note-pmid23758160-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> Certain other progestins act similarly in this assay, whereas progesterone acts neutrally.<span class="mw-ref" id="cite_ref-pmid23758160_87-1"><a href="#cite_note-pmid23758160-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> It is unclear if these findings may explain the different risks of breast cancer observed with progesterone and progestins in clinical studies.<span class="mw-ref" id="cite_ref-pmid31512725_62-3"><a href="#cite_note-pmid31512725-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Absorption">Absorption</h4></summary>
    
<p>The oral bioavailability of drospirenone is between 66 and 85%.<span class="mw-ref" id="cite_ref-Kuhl2005_1-27"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-20"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid23238854_3-8"><a href="#cite_note-pmid23238854-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Peak levels occur 1 to 6<span>&nbsp;</span>hours after an oral dose.<span class="mw-ref" id="cite_ref-Kuhl2005_1-28"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-21"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-23"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Stanczyk2007_78-1"><a href="#cite_note-Stanczyk2007-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> Levels are about 27<span>&nbsp;</span>ng/mL after a single 4<span>&nbsp;</span>mg dose.<span class="mw-ref" id="cite_ref-Slynd-Label_4-24"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> There is 1.5- to 2-fold accumulation in drospirenone levels with continuous administration, with steady-state levels of drospirenone achieved after 7 to 10<span>&nbsp;</span>days of administration.<span class="mw-ref" id="cite_ref-Kuhl2005_1-29"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-25"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-22"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Peak levels of drospirenone at steady state with 4<span>&nbsp;</span>mg/day drospirenone are about 41<span>&nbsp;</span>ng/mL.<span class="mw-ref" id="cite_ref-Slynd-Label_4-26"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> With the combination of 30<span>&nbsp;</span>μg/day ethinylestradiol and 3<span>&nbsp;</span>mg/day drospirenone, peak levels of drospirenone after a single dose are 35<span>&nbsp;</span>ng/mL, and levels at steady state are 60 to 87<span>&nbsp;</span>ng/mL at peak and 20 to 25<span>&nbsp;</span>ng/mL at trough.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-23"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-30"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The pharmacokinetics of oral drospirenone are linear with a single dose across a dose range of 1 to 10<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-Slynd-Label_4-27"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-24"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Intake of drospirenone with food does not influence the absorption of drospirenone.<span class="mw-ref" id="cite_ref-Slynd-Label_4-28"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Distribution">Distribution</h4></summary>
    
<p>The distribution half-life of drospirenone is about 1.6 to 2<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-25"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-31"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The apparent volume of distribution of drospirenone is approximately 4<span>&nbsp;</span>L/kg.<span class="mw-ref" id="cite_ref-Slynd-Label_4-29"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The plasma protein binding of drospirenone is 95 to 97%.<span class="mw-ref" id="cite_ref-Slynd-Label_4-30"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-32"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is bound to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a> and 3 to 5% circulates freely or unbound.<span class="mw-ref" id="cite_ref-Slynd-Label_4-31"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-33"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Drospirenone has no affinity for sex hormone-binding globulin (SHBG) or corticosteroid-binding globulin (CBG), and hence is not bound by these plasma proteins in the circulation.<span class="mw-ref" id="cite_ref-Kuhl2005_1-34"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Metabolism">Metabolism</h4></summary>
    
<p>The metabolism of drospirenone is extensive.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-26"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is metabolized into the acid form of drospirenone by opening of its lactone ring.<span class="mw-ref" id="cite_ref-Kuhl2005_1-35"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-32"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The medication is also metabolized by reduction of its double bond between the C4 and C5 positions and subsequent sulfation.<span class="mw-ref" id="cite_ref-Kuhl2005_1-36"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-33"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The two major metabolites of drospirenone are drospirenone acid and 4,5-dihydrodrospirenone 3-sulfate, and are both formed independently of the cytochrome P450 system.<span class="mw-ref" id="cite_ref-Slynd-Label_4-34"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-27"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Neither of these metabolites are known to be pharmacologically active.<span class="mw-ref" id="cite_ref-Slynd-Label_4-35"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Drospirenone also undergoes oxidative metabolism by CYP3A4.<span class="mw-ref" id="cite_ref-Slynd-Label_4-36"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-28"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Bachmann2009_5-1"><a href="#cite_note-Bachmann2009-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-WiesingerBerse2015_6-1"><a href="#cite_note-WiesingerBerse2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Elimination">Elimination</h4></summary>
    
<p>Drospirenone is excreted in urine and feces, with slightly more excreted in feces than in urine.<span class="mw-ref" id="cite_ref-Slynd-Label_4-37"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Only trace amounts of unchanged drospirenone can be found in urine and feces.<span class="mw-ref" id="cite_ref-Slynd-Label_4-38"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> At least 20 different metabolites can be identified in urine and feces.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-29"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Drospirenone and its metabolites are excreted in urine about 38% as glucuronide conjugates, 47% as sulfate conjugates, and less than 10% in unconjugated form.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-30"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In feces, excretion is about 17% glucuronide conjugates, 20% sulfate conjugates, and 33% unconjugated.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-31"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>The elimination half-life of drospirenone is between 25 and 33<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-Slynd-Label_4-39"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Krattenmacher2000_2-32"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_1-37"><a href="#cite_note-Kuhl2005-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The half-life of drospirenone is unchanged with repeated administration.<span class="mw-ref" id="cite_ref-Slynd-Label_4-40"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Elimination of drospirenone is virtually complete 10<span>&nbsp;</span>days after the last dose.<span class="mw-ref" id="cite_ref-Krattenmacher2000_2-33"><a href="#cite_note-Krattenmacher2000-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Slynd-Label_4-41"><a href="#cite_note-Slynd-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    

<span>
</span><table role="presentation" cellpadding="0" style="border-spacing:0; clear:right; float:right;">
<tbody><tr>
<td><div class="thumb tright">
<div class="thumbinner" style="width:552px; ">
<div style="clear: both; font-weight: bold; font-size: 106.4%; text-align: center; background-color: aliceblue;margin-bottom:3px;"> Chemical structures of spirolactones</div>
<div style="position:relative; width:550px; height:351px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:0px; top:0px; width:550px; position:absolute"> <figure-inline><span><img src="../I/m/Spirolactone_structures.png" tppabs="https://ptable.com/wiki/compounds/I/m/Spirolactone_structures.png" data-file-width="2600" data-file-height="1640" data-file-type="bitmap" height="347" width="550"></span></figure-inline>
</div> 
<div style="text-align:center; font-size:14px; line-height:110%;">
<div style="background-color:transparent; color:black"><div id="annotation_53x134" style="position:absolute; left:53px; top:134px;      line-height:110% "><span style="background-color:transparent; ">Progesterone</span></div>
<div id="annotation_235x134" style="position:absolute; left:235px; top:134px;      line-height:110% "><span style="background-color:transparent; ">Spirolactone</span></div>
<div id="annotation_420x134" style="position:absolute; left:420px; top:134px;      line-height:110% "><span style="background-color:transparent; ">Canrenone</span></div>
<div id="annotation_53x322" style="position:absolute; left:53px; top:322px;      line-height:110% "><span style="background-color:transparent; "><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></span></div>
<div id="annotation_235x322" style="position:absolute; left:235px; top:322px;      line-height:110% "><span style="background-color:transparent; ">Drospirenone</span></div>
<div id="annotation_420x322" style="position:absolute; left:420px; top:322px;      line-height:110% "><span style="background-color:transparent; ">Spirorenone</span></div></div>
</div>
</div>
<div class="thumbcaption" style="clear:left"><div style="float:left;margin-right:0.5em"><figure-inline><span><img src="../I/m/Interactive_icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Interactive_icon.svg.png" data-file-width="133" data-file-height="200" data-file-type="drawing" height="27" width="18"></span></figure-inline></div>Chemical structures of progesterone and spirolactones (steroid-17α-spirolactones).</div>
</div>
</div></td></tr>
</tbody></table>

<p>Drospirenone, also known as 1,2-dihydrospirorenone or as 17β-hydroxy-6β,7β:15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21-carboxylic acid, γ-lactone, is a synthetic steroidal 17α-spirolactone, or more simply a spirolactone.<span class="mw-ref" id="cite_ref-Drugs.com_7-3"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-NegwerScharnow2001_88-0"><a href="#cite_note-NegwerScharnow2001-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> It is an analogue of other spirolactones like <a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">spironolactone</a>, canrenone, and spirorenone.<span class="mw-ref" id="cite_ref-Drugs.com_7-4"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-NegwerScharnow2001_88-1"><a href="#cite_note-NegwerScharnow2001-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> Drospirenone differs structurally from spironolactone only in that the C7α acetylthio substitution of spironolactone has been removed and two methylene groups have been substituted in at the C6β–7β and C15β–16β positions.<span class="mw-ref" id="cite_ref-Carp2015_89-0"><a href="#cite_note-Carp2015-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span></p>

<p>Spirolactones like drospirenone and spironolactone are derivatives of progesterone, which likewise has progestogenic and antimineralocorticoid activity.<span class="mw-ref" id="cite_ref-pmid15134800_90-0"><a href="#cite_note-pmid15134800-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-JamesonGroot2010_91-0"><a href="#cite_note-JamesonGroot2010-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span><span class="mw-ref" id="cite_ref-Elsevier2019_92-0"><a href="#cite_note-Elsevier2019-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-Elsevier2019_92-1"><a href="#cite_note-Elsevier2019-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span> The loss of the C7α acetylthio group of spironolactone, a compound with negligible progestogenic activity,<span class="mw-ref" id="cite_ref-pmid16101407_93-0"><a href="#cite_note-pmid16101407-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-pmid2744183_94-0"><a href="#cite_note-pmid2744183-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> appears to be involved in the restoration of progestogenic activity in drospirenone, as SC-5233, the analogue of spironolactone without a C7α substitution, has potent progestogenic activity similarly to drospirenone.<span class="mw-ref" id="cite_ref-pmid13601900_95-0"><a href="#cite_note-pmid13601900-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Drospirenone was patented in 1976 and introduced for medical use in 2000.<span class="mw-ref" id="cite_ref-Ravina2011_11-1"><a href="#cite_note-Ravina2011-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Fis2006_12-1"><a href="#cite_note-Fis2006-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Schering AG of Germany has been granted several patents on the production of drospirenone, including WIPO and US patents, granted in 1998 and 2000, respectively.<span class="mw-ref" id="cite_ref-96"><a href="#cite_note-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> It was introduced for medical use in combination with ethinylestradiol as a combined birth control pill in 2000.<span class="mw-ref" id="cite_ref-Ravina2011_11-2"><a href="#cite_note-Ravina2011-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Drospirenone is sometimes described as a "fourth-generation" progestin based on its time of introduction.<span class="mw-ref" id="cite_ref-HatcherM.D.2007_13-1"><a href="#cite_note-HatcherM.D.2007-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-RossoZeichner2016_14-1"><a href="#cite_note-RossoZeichner2016-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The medication was approved for use in menopausal hormone therapy in combination with estradiol in 2005.<span class="mw-ref" id="cite_ref-AdisInsight-Angeliq_21-2"><a href="#cite_note-AdisInsight-Angeliq-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Drospirenone was introduced for use as a progestogen-only birth control pill in 2019.<span class="mw-ref" id="cite_ref-AdisInsight-Slynd_18-2"><a href="#cite_note-AdisInsight-Slynd-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Drospirenone</i> is the generic name of the drug and its <abbr>INN</abbr>, <abbr>USAN</abbr>, <abbr>BAN</abbr>, and <abbr>JAN</abbr>, while <i>drospirénone</i> is its <abbr>DCF</abbr>.<span class="mw-ref" id="cite_ref-Drugs.com_7-5"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Its name is a shortened form of the name <i>1,2-dihydrospirorenone</i> or <i>dihydrospirenone</i>.<span class="mw-ref" id="cite_ref-Drugs.com_7-6"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-NegwerScharnow2001_88-2"><a href="#cite_note-NegwerScharnow2001-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> Drospirenone is also known by its developmental code names <i>SH-470</i> and <i>ZK-30595</i> (alone), <i>BAY 86-5300</i>, <i>BAY 98-7071</i>, and <i>SH-T-00186D</i> (in combination with ethinylestradiol), and <i>BAY 86-4891</i> (in combination with estradiol).<span class="mw-ref" id="cite_ref-Drugs.com_7-7"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-NegwerScharnow2001_88-3"><a href="#cite_note-NegwerScharnow2001-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-AdisInsight-EE/DRSP_98-0"><a href="#cite_note-AdisInsight-EE/DRSP-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span><span class="mw-ref" id="cite_ref-EE/DRSP/FA_99-0"><a href="#cite_note-EE/DRSP/FA-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span><span class="mw-ref" id="cite_ref-EE/DRSP-Low_100-0"><a href="#cite_note-EE/DRSP-Low-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span><span class="mw-ref" id="cite_ref-E2/DRSP_101-0"><a href="#cite_note-E2/DRSP-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Drospirenone is marketed in combination with an estrogen under a variety of brand names throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_7-8"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Among others, it is marketed in combination with ethinylestradiol under the brand names Yasmin and Yaz and in combination with estradiol under the brand name Angeliq.<span class="mw-ref" id="cite_ref-Drugs.com_7-9"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    


<p>Drospirenone is marketed widely throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_7-10"><a href="#cite_note-Drugs.com-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generation">Generation</h3></summary>
    
<p>Drospirenone has been categorized as a "fourth-generation" progestin.<span class="mw-ref" id="cite_ref-pmid21414337_58-9"><a href="#cite_note-pmid21414337-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Litigation">Litigation</h3></summary>
    
<p>Many lawsuits have been filed against Bayer, the manufacturer of drospirenone, due to the higher risk of VTE that has been observed with combined birth control pills containing drospirenone and certain other progestins relative to the risk with levonorgestrel-containing combined birth control pills.<span class="mw-ref" id="cite_ref-pmid27854556_48-2"><a href="#cite_note-pmid27854556-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>In July 2012, Bayer notified its stockholders that there were more than 12,000 such lawsuits against the company involving Yaz, Yasmin, and other birth control pills with drospirenone.<span class="mw-ref" id="cite_ref-Feeley_2012_102-0"><a href="#cite_note-Feeley_2012-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> They also noted that the company by then had settled 1,977 cases for US$402.6 million, for an average of US$212,000 per case, while setting aside US$610.5 million to settle the others.<span class="mw-ref" id="cite_ref-Feeley_2012_102-1"><a href="#cite_note-Feeley_2012-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span></p>

<p>As of July 17, 2015, there have been at least 4,000 lawsuits and claims still pending regarding VTE related to drospirenone.<span class="mw-ref" id="cite_ref-Bayer2015_103-0"><a href="#cite_note-Bayer2015-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> This is in addition to around 10,000 claims that Bayer has already settled without admitting liability.<span class="mw-ref" id="cite_ref-Bayer2015_103-1"><a href="#cite_note-Bayer2015-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> These claims of VTE have amounted to US$1.97 billion.<span class="mw-ref" id="cite_ref-Bayer2015_103-2"><a href="#cite_note-Bayer2015-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> Bayer also reached a settlement for arterial thromboembolic events, including stroke and heart attacks, for US$56.9 million.<span class="mw-ref" id="cite_ref-Bayer2015_103-3"><a href="#cite_note-Bayer2015-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    


<p>Drospirenone is under development by Mithra Pharmaceuticals in combination with estetrol (tentative brand name Estelle) as a combined birth control pill for prevention of pregnancy in women.<span class="mw-ref" id="cite_ref-AdisInsight-E4-DRSP_104-0"><a href="#cite_note-AdisInsight-E4-DRSP-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span> As of October 2019, it is in phase III clinical trials.<span class="mw-ref" id="cite_ref-AdisInsight-E4-DRSP_104-1"><a href="#cite_note-AdisInsight-E4-DRSP-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>

<p>A combination of ethinylestradiol, drospirenone, and prasterone is under development by Pantarhei Bioscience as a combined birth control pill for prevention of pregnancy in women.<span class="mw-ref" id="cite_ref-AdisInsight-EE-DRSP-DHEA_105-0"><a href="#cite_note-AdisInsight-EE-DRSP-DHEA-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> It includes prasterone (dehydroepiandrosterone; DHEA), an oral androgen prohormone, to replace testosterone and avoid testosterone deficiency caused by suppression of testosterone by ethinylestradiol and drospirenone.<span class="mw-ref" id="cite_ref-AdisInsight-EE-DRSP-DHEA_105-1"><a href="#cite_note-AdisInsight-EE-DRSP-DHEA-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> As of August 2018, the formulation is in phase II/III clinical trials.<span class="mw-ref" id="cite_ref-AdisInsight-EE-DRSP-DHEA_105-2"><a href="#cite_note-AdisInsight-EE-DRSP-DHEA-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span></p>

<p>Drospirenone has been suggested for potential use as a progestin in male hormonal contraception.<span class="mw-ref" id="cite_ref-CorniaAnawalt2005_75-1"><a href="#cite_note-CorniaAnawalt2005-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>

<p>Drospirenone has been studied in forms for parenteral administration.<span class="mw-ref" id="cite_ref-pmid21729745_106-0"><a href="#cite_note-pmid21729745-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-pmid22940138_107-0"><a href="#cite_note-pmid22940138-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span><span class="mw-ref" id="cite_ref-pmid23116659_108-0"><a href="#cite_note-pmid23116659-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span><span class="mw-ref" id="cite_ref-pmid24621345_109-0"><a href="#cite_note-pmid24621345-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Ethinylestradiol/drospirenone</li>
<li>Ethinylestradiol/drospirenone/levomefolic acid</li>
<li>Estradiol/drospirenone</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Kuhl2005-1"> <span id="mw-reference-text-cite_note-Kuhl2005-1" class="mw-reference-text"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl, H (2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration". <i>Climacteric</i>. <b>8</b> (sup1): 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1369-7137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1369-7137'" tppabs="https://www.worldcat.org/issn/1369-7137" class="external text external">1369-7137</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>.</cite></span></li><li id="cite_note-Krattenmacher2000-2"> <span id="mw-reference-text-cite_note-Krattenmacher2000-2" class="mw-reference-text"><cite id="CITEREFKrattenmacher2000" class="citation journal cs1">Krattenmacher, Rolf (2000). "Drospirenone: pharmacology and pharmacokinetics of a unique progestogen". <i>Contraception</i>. <b>62</b> (1): 29–38. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0010-7824%2800%2900133-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0010-7824%2800%2900133-5'" tppabs="https://doi.org/10.1016%2FS0010-7824%2800%2900133-5" class="external text external">10.1016/S0010-7824(00)00133-5</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11024226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11024226'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11024226" class="external text external">11024226</a>.</cite></span></li><li id="cite_note-pmid23238854-3"> <span id="mw-reference-text-cite_note-pmid23238854-3" class="mw-reference-text"><cite id="CITEREFStanczykHapgoodWinerMishell2013" class="citation journal cs1">Stanczyk FZ, Hapgood JP, Winer S, Mishell DR (April 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676" class="external text external">"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects"</a>. <i>Endocr. Rev</i>. <b>34</b> (2): 171–208. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fer.2012-1008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fer.2012-1008'" tppabs="https://doi.org/10.1210%2Fer.2012-1008" class="external text external">10.1210/er.2012-1008</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610676" class="external text external">3610676</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23238854  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23238854'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23238854" class="external text external">23238854</a>.</cite></span></li><li id="cite_note-Slynd-Label-4"> <span id="mw-reference-text-cite_note-Slynd-Label-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf" class="external text external">"Drospirenone tablets, for oral use"</a> <span class="cs1-format">(PDF)</span>. <i>FDA</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 November</span> 2019</span>.</cite></span></li><li id="cite_note-Bachmann2009-5"> <span id="mw-reference-text-cite_note-Bachmann2009-5" class="mw-reference-text"><cite id="CITEREFBachmann2009" class="citation journal cs1">Bachmann, Gloria (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416" class="external text external">"Drospirenone/ethinyl estradiol 3 mg/20 <span>µ</span>g (24/4 day regimen): hormonal contraceptive choices <span>–</span> use of a fourth-generation progestin"</a>. <i>Patient Preference and Adherence</i>. <b>3</b>: 259–64. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FPPA.S3901  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FPPA.S3901'" tppabs="https://doi.org/10.2147%2FPPA.S3901" class="external text external">10.2147/PPA.S3901</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1177-889X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1177-889X'" tppabs="https://www.worldcat.org/issn/1177-889X" class="external text external">1177-889X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778416" class="external text external">2778416</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19936169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19936169'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19936169" class="external text external">19936169</a>.</cite></span></li><li id="cite_note-WiesingerBerse2015-6"> <span id="mw-reference-text-cite_note-WiesingerBerse2015-6" class="mw-reference-text"><cite id="CITEREFWiesingerBerseKleinGschwend2015" class="citation journal cs1">Wiesinger, Herbert; Berse, Matthias; Klein, Stefan; Gschwend, Simone; Höchel, Joachim; Zollmann, Frank S.; Schütt, Barbara (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482" class="external text external">"Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>80</b> (6): 1399–1410. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fbcp.12745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fbcp.12745'" tppabs="https://doi.org/10.1111%2Fbcp.12745" class="external text external">10.1111/bcp.12745</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0306-5251  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0306-5251'" tppabs="https://www.worldcat.org/issn/0306-5251" class="external text external">0306-5251</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693482" class="external text external">4693482</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26271371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26271371'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26271371" class="external text external">26271371</a>.</cite></span></li><li id="cite_note-Drugs.com-7"> <span id="mw-reference-text-cite_note-Drugs.com-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/drospirenone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/drospirenone.html'" tppabs="https://www.drugs.com/international/drospirenone.html" class="external text external">"Drospirenone"</a>.</cite></span></li><li id="cite_note-pmid26598309-8"> <span id="mw-reference-text-cite_note-pmid26598309-8" class="mw-reference-text"><cite id="CITEREFHanJensen2015" class="citation journal cs1">Han L, Jensen JT (December 2015). <a href="javascript:if(confirm('https://doi.org/10.1016/j.ogc.2015.07.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.ogc.2015.07.007'" tppabs="https://doi.org/10.1016/j.ogc.2015.07.007" class="external text external">"Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?"</a>. <i>Obstet. Gynecol. Clin. North Am</i>. <b>42</b> (4): 683–98. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ogc.2015.07.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ogc.2015.07.007'" tppabs="https://doi.org/10.1016%2Fj.ogc.2015.07.007" class="external text external">10.1016/j.ogc.2015.07.007</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26598309  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26598309'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26598309" class="external text external">26598309</a>.</cite></span></li><li id="cite_note-pmid11246598-9"> <span id="mw-reference-text-cite_note-pmid11246598-9" class="mw-reference-text"><cite id="CITEREFOelkers2000" class="citation journal cs1">Oelkers W (December 2000). "Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone". <i>Eur J Contracept Reprod Health Care</i>. 5 Suppl 3: 17–24. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11246598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11246598'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11246598" class="external text external">11246598</a>.</cite></span></li><li id="cite_note-pmid12659403-10"> <span id="mw-reference-text-cite_note-pmid12659403-10" class="mw-reference-text"><cite id="CITEREFOelkers2002" class="citation journal cs1">Oelkers W (December 2002). "Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone". <i>Eur J Contracept Reprod Health Care</i>. 7 Suppl 3: 19–26, discussion 42–3. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12659403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12659403'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12659403" class="external text external">12659403</a>.</cite></span></li><li id="cite_note-Ravina2011-11"> <span id="mw-reference-text-cite_note-Ravina2011-11" class="mw-reference-text"><cite id="CITEREFEnrique_Ravina2011" class="citation book cs1">Enrique Ravina (11 January 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA193  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA193'" tppabs="https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA193" class="external text external"><i>The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>193–. ISBN<span>&nbsp;</span><bdi>978-3-527-32669-3</bdi>.</cite></span></li><li id="cite_note-Fis2006-12"> <span id="mw-reference-text-cite_note-Fis2006-12" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA459'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA459" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>459. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-HatcherM.D.2007-13"> <span id="mw-reference-text-cite_note-HatcherM.D.2007-13" class="mw-reference-text"><cite id="CITEREFRobert_Anthony_HatcherAnita_L._Nelson,_M.D.2007" class="citation book cs1">Robert Anthony Hatcher; Anita L. Nelson, M.D. (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=txh0LpjjhkoC&pg=PA196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=txh0LpjjhkoC&pg=PA196'" tppabs="https://books.google.com/books?id=txh0LpjjhkoC&pg=PA196" class="external text external"><i>Contraceptive Technology</i></a>. Ardent Media. pp.<span>&nbsp;</span>196–. ISBN<span>&nbsp;</span><bdi>978-1-59708-001-9</bdi>.</cite></span></li><li id="cite_note-RossoZeichner2016-14"> <span id="mw-reference-text-cite_note-RossoZeichner2016-14" class="mw-reference-text"><cite id="CITEREFJames_Q._Del_RossoJoshua_A._Zeichner2016" class="citation book cs1">James Q. Del Rosso; Joshua A. Zeichner (20 April 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Au8VDAAAQBAJ&pg=PA160  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Au8VDAAAQBAJ&pg=PA160'" tppabs="https://books.google.com/books?id=Au8VDAAAQBAJ&pg=PA160" class="external text external"><i>Advances in Acne Management, An Issue of Dermatologic Clinics, E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>160–. ISBN<span>&nbsp;</span><bdi>978-0-323-41753-2</bdi>.</cite></span></li><li id="cite_note-Drugs.com-Generic-15"> <span id="mw-reference-text-cite_note-Drugs.com-Generic-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/availability/generic-yasmin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/availability/generic-yasmin.html'" tppabs="https://www.drugs.com/availability/generic-yasmin.html" class="external text external">"Generic Yasmin Availability"</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/DrospirenoneEthinylEstradiol  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/DrospirenoneEthinylEstradiol'" tppabs="https://clincalc.com/DrugStats/Drugs/DrospirenoneEthinylEstradiol" class="external text external">"Drospirenone; Ethinyl Estradiol - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-AdisInsight-Slynd-18"> <span id="mw-reference-text-cite_note-AdisInsight-Slynd-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800053493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800053493'" tppabs="https://adisinsight.springer.com/drugs/800053493" class="external text external">"Drospirenone - Exeltis USA - AdisInsight"</a>.</cite></span></li><li id="cite_note-AdisInsight-Yaz-19"> <span id="mw-reference-text-cite_note-AdisInsight-Yaz-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800017043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800017043'" tppabs="https://adisinsight.springer.com/drugs/800017043" class="external text external">"Drospirenone/ethinylestradiol low-dose - Bayer HealthCare Pharmaceuticals - AdisInsight"</a>. <i>adisinsight.springer.com</i>.</cite></span></li><li id="cite_note-Drugs.com-EE/DRSP-20"> <span id="mw-reference-text-cite_note-Drugs.com-EE/DRSP-20" class="mw-reference-text"><cite id="CITEREFCerner_Multum,_Inc.2012" class="citation web cs1">Cerner Multum, Inc. (June 11, 2012). <a href="javascript:if(confirm('https://www.drugs.com/mtm/drospirenone-and-ethinyl-estradiol.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/mtm/drospirenone-and-ethinyl-estradiol.html'" tppabs="https://www.drugs.com/mtm/drospirenone-and-ethinyl-estradiol.html" class="external text external">"drospirenone and ethinyl estradiol"</a>. Auckland, New Zealand: Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">October 24,</span> 2011</span>.</cite></span></li><li id="cite_note-AdisInsight-Angeliq-21"> <span id="mw-reference-text-cite_note-AdisInsight-Angeliq-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800014148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800014148'" tppabs="https://adisinsight.springer.com/drugs/800014148" class="external text external">"Estradiol/drospirenone - Bayer HealthCare Pharmaceuticals - AdisInsight"</a>. <i>adisinsight.springer.com</i>.</cite></span></li><li id="cite_note-Angeliq-Label-22"> <span id="mw-reference-text-cite_note-Angeliq-Label-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf" class="external text external">"ANGELIQ Tablets"</a> <span class="cs1-format">(PDF)</span>. Food and Drug Administration.</cite></span></li><li id="cite_note-pmid15495039-23"> <span id="mw-reference-text-cite_note-pmid15495039-23" class="mw-reference-text"><cite id="CITEREFMaclennanBroadbentLesterMoore2004" class="citation journal cs1">Maclennan, A. H.; Broadbent, J. L.; Lester, S.; Moore, V. (18 October 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247" class="external text external">"Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes"</a>. <i>The Cochrane Database of Systematic Reviews</i> (4): CD002978. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD002978.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD002978.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD002978.pub2" class="external text external">10.1002/14651858.CD002978.pub2</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1469-493X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1469-493X'" tppabs="https://www.worldcat.org/issn/1469-493X" class="external text external">1469-493X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004247" class="external text external">7004247</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15495039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15495039'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15495039" class="external text external">15495039</a>.</cite></span></li><li id="cite_note-pmid11401611-24"> <span id="mw-reference-text-cite_note-pmid11401611-24" class="mw-reference-text"><cite id="CITEREFTorgersonBell-Syer2001" class="citation journal cs1">Torgerson, D. J.; Bell-Syer, S. E. (13 June 2001). "Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials". <i>JAMA</i>. <b>285</b> (22): 2891–2897. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.285.22.2891  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.285.22.2891'" tppabs="https://doi.org/10.1001%2Fjama.285.22.2891" class="external text external">10.1001/jama.285.22.2891</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0098-7484  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0098-7484'" tppabs="https://www.worldcat.org/issn/0098-7484" class="external text external">0098-7484</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11401611  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11401611'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11401611" class="external text external">11401611</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:25078579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:25078579'" tppabs="https://api.semanticscholar.org/CorpusID:25078579" class="external text external">25078579</a>.</cite></span></li><li id="cite_note-pmid16513012-25"> <span id="mw-reference-text-cite_note-pmid16513012-25" class="mw-reference-text"><cite id="CITEREFWhitehead2006" class="citation journal cs1">Whitehead M (March 2006). "Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data". <i>J Br Menopause Soc</i>. 12 Suppl 1: 4–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1258%2F136218006775992185  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1258%2F136218006775992185'" tppabs="https://doi.org/10.1258%2F136218006775992185" class="external text external">10.1258/136218006775992185</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16513012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16513012'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16513012" class="external text external">16513012</a>.</cite></span></li><li id="cite_note-pmid28217493-26"> <span id="mw-reference-text-cite_note-pmid28217493-26" class="mw-reference-text"><cite id="CITEREFMajumderSanyal2017" class="citation journal cs1">Majumder A, Sanyal D (2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066" class="external text external">"Outcome and preferences in male-to-female subjects with gender dysphoria: Experience from Eastern India"</a>. <i>Indian J Endocrinol Metab</i>. <b>21</b> (1): 21–25. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2F2230-8210.196000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2F2230-8210.196000'" tppabs="https://doi.org/10.4103%2F2230-8210.196000" class="external text external">10.4103/2230-8210.196000</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240066" class="external text external">5240066</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28217493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28217493'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28217493" class="external text external">28217493</a>.</cite></span></li><li id="cite_note-MajumderChatterjee2020-27"> <span id="mw-reference-text-cite_note-MajumderChatterjee2020-27" class="mw-reference-text"><cite id="CITEREFMajumderChatterjeeMajiRoychaudhuri2020" class="citation journal cs1">Majumder, Anirban; Chatterjee, Sudip; Maji, Debasis; Roychaudhuri, Soumyabrata; Ghosh, Sujoy; Selvan, Chitra; George, Belinda; Kalra, Pramila; Maisnam, Indira; Sanyal, Debmalya (2020). "IDEA group consensus statement on medical management of adult gender incongruent individuals seeking gender reaffirmation as female". <i>Indian Journal of Endocrinology and Metabolism</i>. <b>24</b> (2): 128. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2Fijem.IJEM_593_19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2Fijem.IJEM_593_19'" tppabs="https://doi.org/10.4103%2Fijem.IJEM_593_19" class="external text external">10.4103/ijem.IJEM_593_19</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2230-8210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2230-8210'" tppabs="https://www.worldcat.org/issn/2230-8210" class="external text external">2230-8210</a>.</cite></span></li><li id="cite_note-pmid28477648-28"> <span id="mw-reference-text-cite_note-pmid28477648-28" class="mw-reference-text"><cite id="CITEREFLanza_di_Scalea2017" class="citation journal cs1">Lanza di Scalea, Teresa (June 2017). "Premenstrual Dysphoric Disorder". <i>Psychiatric Clinics of North America</i>. <b>40</b> (2): 201–206. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.psc.2017.01.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.psc.2017.01.002'" tppabs="https://doi.org/10.1016%2Fj.psc.2017.01.002" class="external text external">10.1016/j.psc.2017.01.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28477648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28477648'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28477648" class="external text external">28477648</a>.</cite></span></li><li id="cite_note-pmid22336820-29"> <span id="mw-reference-text-cite_note-pmid22336820-29" class="mw-reference-text"><cite id="CITEREFLopezKapteinHelmerhorst2012" class="citation journal cs1">Lopez LM, Kaptein AA, Helmerhorst FM (February 2012). "Oral contraceptives containing drospirenone for premenstrual syndrome". <i>Cochrane Database Syst Rev</i> (2): CD006586. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD006586.pub4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD006586.pub4'" tppabs="https://doi.org/10.1002%2F14651858.CD006586.pub4" class="external text external">10.1002/14651858.CD006586.pub4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22336820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22336820'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22336820" class="external text external">22336820</a>.</cite></span></li><li id="cite_note-pmid16203654-30"> <span id="mw-reference-text-cite_note-pmid16203654-30" class="mw-reference-text"><cite id="CITEREFChristiansen2005" class="citation journal cs1">Christiansen C (October 2005). "Effects of drospirenone/estrogen combinations on bone metabolism". <i>Climacteric</i>. 8 Suppl 3: 35–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500330283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500330283'" tppabs="https://doi.org/10.1080%2F13697130500330283" class="external text external">10.1080/13697130500330283</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16203654  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16203654'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16203654" class="external text external">16203654</a>.</cite></span></li><li id="cite_note-pmid17364592-31"> <span id="mw-reference-text-cite_note-pmid17364592-31" class="mw-reference-text"><cite id="CITEREFArcher2007" class="citation journal cs1">Archer DF (February 2007). "Drospirenone and estradiol: a new option for the postmenopausal woman". <i>Climacteric</i>. 10 Suppl 1: 3–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130601114859  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130601114859'" tppabs="https://doi.org/10.1080%2F13697130601114859" class="external text external">10.1080/13697130601114859</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17364592  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17364592'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17364592" class="external text external">17364592</a>.</cite></span></li><li id="cite_note-pmid19357298-32"> <span id="mw-reference-text-cite_note-pmid19357298-32" class="mw-reference-text"><cite class="citation journal cs1">"Drospirenone in HRT?". <i>Drug Ther Bull</i>. <b>47</b> (4): 41–4. April 2009. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fdtb.2009.03.0011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fdtb.2009.03.0011'" tppabs="https://doi.org/10.1136%2Fdtb.2009.03.0011" class="external text external">10.1136/dtb.2009.03.0011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19357298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19357298'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19357298" class="external text external">19357298</a>.</cite></span></li><li id="cite_note-pmid18075844-33"> <span id="mw-reference-text-cite_note-pmid18075844-33" class="mw-reference-text"><cite id="CITEREFFoidartFaustmann2007" class="citation journal cs1">Foidart JM, Faustmann T (December 2007). "Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen". <i>Gynecol. Endocrinol</i>. <b>23</b> (12): 692–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F09513590701582323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F09513590701582323'" tppabs="https://doi.org/10.1080%2F09513590701582323" class="external text external">10.1080/09513590701582323</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18075844  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18075844'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18075844" class="external text external">18075844</a>.</cite></span></li><li id="cite_note-Drugs@FDA-34"> <span id="mw-reference-text-cite_note-Drugs@FDA-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/daf/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/daf/'" tppabs="http://www.accessdata.fda.gov/scripts/cder/daf/" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>. United States Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2019</span>.</cite></span></li><li id="cite_note-FDADrugSafety-35"> <span id="mw-reference-text-cite_note-FDADrugSafety-35" class="mw-reference-text"><cite id="CITEREFResearch" class="citation web cs1">Research, Center for Drug Evaluation and. <a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/ucm299305.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/ucm299305.htm#table'" tppabs="https://www.fda.gov/Drugs/DrugSafety/ucm299305.htm#table" class="external text external">"Drug Safety and Availability - FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone"</a>. <i>www.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-11-07</span></span>.</cite></span></li><li id="cite_note-Yasmin-Label-36"> <span id="mw-reference-text-cite_note-Yasmin-Label-36" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021098s028lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021098s028lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021098s028lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021098s028lbl.pdf</a></span></li><li id="cite_note-AdisInsight-Yasmin-37"> <span id="mw-reference-text-cite_note-AdisInsight-Yasmin-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800007379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800007379'" tppabs="https://adisinsight.springer.com/drugs/800007379" class="external text external">"Ethinylestradiol/drospirenone - AdisInsight"</a>. <i>adisinsight.springer.com</i>.</cite></span></li><li id="cite_note-AdisInsight-Beyaz-38"> <span id="mw-reference-text-cite_note-AdisInsight-Beyaz-38" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800032716  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800032716'" tppabs="https://adisinsight.springer.com/drugs/800032716" class="external text external">"Ethinylestradiol/drospirenone/folic acid - AdisInsight"</a>. <i>adisinsight.springer.com</i>.</cite></span></li><li id="cite_note-Beyaz-Label-39"> <span id="mw-reference-text-cite_note-Beyaz-Label-39" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s001lbl.pdf</a></span></li><li id="cite_note-Yaz-Label-40"> <span id="mw-reference-text-cite_note-Yaz-Label-40" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf" class="external text external">"Yaz"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">October 31,</span> 2017</span>.</cite></span></li><li id="cite_note-Yasmin_SPC_2013-41"> <span id="mw-reference-text-cite_note-Yasmin_SPC_2013-41" class="mw-reference-text"><cite id="CITEREFBayer2013" class="citation web cs1">Bayer (March 25, 2013). <a href="javascript:if(confirm('http://www.medicines.org.uk/emc/medicine/8777/SPC/Yasmin+film-coated+tablets+0.03mg+3mg/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicines.org.uk/emc/medicine/8777/SPC/Yasmin+film-coated+tablets+0.03mg+3mg/'" tppabs="http://www.medicines.org.uk/emc/medicine/8777/SPC/Yasmin+film-coated+tablets+0.03mg+3mg/" class="external text external">"Summary of Product Characteristics (SPC): Yasmin"</a>. London: electronic Medicines Compendium (eMC), Datapharm<span class="reference-accessdate">. Retrieved <span class="nowrap">April 24,</span> 2014</span>. <q>4.3. Contraindications: • Severe chronic kidney disease or acute kidney failure. • Presence or history of severe hepatic disease as long as liver function values have not returned to normal.</q></cite></span></li><li id="cite_note-Yasmin_PI_2012-42"> <span id="mw-reference-text-cite_note-Yasmin_PI_2012-42" class="mw-reference-text"><cite id="CITEREFBayer2012" class="citation web cs1">Bayer (April 10, 2012). <a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021098s022lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021098s022lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021098s022lbl.pdf" class="external text external">"Yasmin full prescribing information"</a> <span class="cs1-format">(PDF)</span>. Silver Spring, Md.: Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">April 14,</span> 2012</span>. <q>4. Contraindications: • Renal impairment. • Adrenal insufficiency. • Liver disease.</q></cite></span></li><li id="cite_note-Nelson_2011-43"> <span id="mw-reference-text-cite_note-Nelson_2011-43" class="mw-reference-text"><cite id="CITEREFNelsonCwiak2011" class="citation book cs1">Nelson, Anita L.; Cwiak, Carrie (2011). "Combined oral contraceptives (COCs)".  In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). <i>Contraceptive Technology</i> (20th revised ed.). New York: Ardent Media. pp.<span>&nbsp;</span>249–341. ISBN<span>&nbsp;</span><bdi>978-1-59708-004-0</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0091-9721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0091-9721'" tppabs="https://www.worldcat.org/issn/0091-9721" class="external text external">0091-9721</a>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/781956734  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/781956734'" tppabs="https://www.worldcat.org/oclc/781956734" class="external text external">781956734</a>.</cite></span></li><li id="cite_note-pmid26780736-44"> <span id="mw-reference-text-cite_note-pmid26780736-44" class="mw-reference-text"><cite id="CITEREFHeitSpencerWhite2016" class="citation journal cs1">Heit JA, Spencer FA, White RH (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842" class="external text external">"The epidemiology of venous thromboembolism"</a>. <i>J. Thromb. Thrombolysis</i>. <b>41</b> (1): 3–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11239-015-1311-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11239-015-1311-6'" tppabs="https://doi.org/10.1007%2Fs11239-015-1311-6" class="external text external">10.1007/s11239-015-1311-6</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715842" class="external text external">4715842</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26780736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26780736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26780736" class="external text external">26780736</a>.</cite></span></li><li id="cite_note-pmid27051991-45"> <span id="mw-reference-text-cite_note-pmid27051991-45" class="mw-reference-text"><cite id="CITEREFBatesonButcherDonovanFarrell2016" class="citation journal cs1">Bateson D, Butcher BE, Donovan C, Farrell L, Kovacs G, Mezzini T, Raynes-Greenow C, Pecoraro G, Read C, Baber R (2016). <a href="javascript:if(confirm('https://www.racgp.org.au/afp/2016/januaryfebruary/risk-of-venous-thromboembolism-in-women-taking-the-combined-oral-contraceptive-a-systematic-review-and-meta-analysis/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.racgp.org.au/afp/2016/januaryfebruary/risk-of-venous-thromboembolism-in-women-taking-the-combined-oral-contraceptive-a-systematic-review-and-meta-analysis/'" tppabs="https://www.racgp.org.au/afp/2016/januaryfebruary/risk-of-venous-thromboembolism-in-women-taking-the-combined-oral-contraceptive-a-systematic-review-and-meta-analysis/" class="external text external">"Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis"</a>. <i>Aust Fam Physician</i>. <b>45</b> (1): 59–64. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27051991  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27051991'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27051991" class="external text external">27051991</a>.</cite></span></li><li id="cite_note-FDA2018-46"> <span id="mw-reference-text-cite_note-FDA2018-46" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20190427143241/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190427143241/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control'" tppabs="https://web.archive.org/web/20190427143241/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control" class="external text external">"FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone"</a>. April 27, 2019. Archived from <a href="javascript:if(confirm('https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control'" tppabs="https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control" class="external text external">the original</a> on 2019-04-27.</cite></span></li><li id="cite_note-pmid30626577-47"> <span id="mw-reference-text-cite_note-pmid30626577-47" class="mw-reference-text"><cite id="CITEREFVinogradovaCouplandHippisley-Cox2019" class="citation journal cs1">Vinogradova Y, Coupland C, Hippisley-Cox J (January 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068" class="external text external">"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases"</a>. <i>BMJ</i>. <b>364</b>: k4810. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.k4810  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.k4810'" tppabs="https://doi.org/10.1136%2Fbmj.k4810" class="external text external">10.1136/bmj.k4810</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326068" class="external text external">6326068</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30626577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30626577'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30626577" class="external text external">30626577</a>.</cite></span></li><li id="cite_note-pmid27854556-48"> <span id="mw-reference-text-cite_note-pmid27854556-48" class="mw-reference-text"><cite id="CITEREFBaturCasey2017" class="citation journal cs1">Batur P, Casey PM (February 2017). "Drospirenone Litigation: Does the Punishment Fit the Crime?". <i>J Womens Health (Larchmt)</i>. <b>26</b> (2): 99–102. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fjwh.2016.6092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fjwh.2016.6092'" tppabs="https://doi.org/10.1089%2Fjwh.2016.6092" class="external text external">10.1089/jwh.2016.6092</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27854556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27854556'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27854556" class="external text external">27854556</a>.</cite></span></li><li id="cite_note-pmid27678035-49"> <span id="mw-reference-text-cite_note-pmid27678035-49" class="mw-reference-text"><cite id="CITEREFSitruk-Ware2016" class="citation journal cs1">Sitruk-Ware R (November 2016). <a href="javascript:if(confirm('https://doi.org/10.1016/j.fertnstert.2016.08.039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.fertnstert.2016.08.039'" tppabs="https://doi.org/10.1016/j.fertnstert.2016.08.039" class="external text external">"Hormonal contraception and thrombosis"</a>. <i>Fertil. Steril</i>. <b>106</b> (6): 1289–1294. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.fertnstert.2016.08.039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.fertnstert.2016.08.039'" tppabs="https://doi.org/10.1016%2Fj.fertnstert.2016.08.039" class="external text external">10.1016/j.fertnstert.2016.08.039</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27678035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27678035'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27678035" class="external text external">27678035</a>.</cite></span></li><li id="cite_note-pmid29573722-50"> <span id="mw-reference-text-cite_note-pmid29573722-50" class="mw-reference-text"><cite id="CITEREFOedingenScholzRazum2018" class="citation journal cs1">Oedingen C, Scholz S, Razum O (May 2018). "Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose". <i>Thromb. Res</i>. <b>165</b>: 68–78. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.thromres.2018.03.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.thromres.2018.03.005'" tppabs="https://doi.org/10.1016%2Fj.thromres.2018.03.005" class="external text external">10.1016/j.thromres.2018.03.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29573722  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29573722'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29573722" class="external text external">29573722</a>.</cite></span></li><li id="cite_note-pmid29388678-51"> <span id="mw-reference-text-cite_note-pmid29388678-51" class="mw-reference-text"><cite id="CITEREFDragomanTepperFuCurtis2018" class="citation journal cs1">Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME (June 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307" class="external text external">"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception"</a>. <i>Int J Gynaecol Obstet</i>. <b>141</b> (3): 287–294. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fijgo.12455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fijgo.12455'" tppabs="https://doi.org/10.1002%2Fijgo.12455" class="external text external">10.1002/ijgo.12455</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969307" class="external text external">5969307</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29388678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29388678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29388678" class="external text external">29388678</a>.</cite></span></li><li id="cite_note-pmid17056444-52"> <span id="mw-reference-text-cite_note-pmid17056444-52" class="mw-reference-text"><cite id="CITEREFWiegratzKuhl2006" class="citation journal cs1">Wiegratz I, Kuhl H (September 2006). "Metabolic and clinical effects of progestogens". <i>Eur J Contracept Reprod Health Care</i>. <b>11</b> (3): 153–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13625180600772741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13625180600772741'" tppabs="https://doi.org/10.1080%2F13625180600772741" class="external text external">10.1080/13625180600772741</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17056444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17056444'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17056444" class="external text external">17056444</a>.</cite></span></li><li id="cite_note-pmid8794429-53"> <span id="mw-reference-text-cite_note-pmid8794429-53" class="mw-reference-text"><cite id="CITEREFKuhl1996" class="citation journal cs1">Kuhl H (May 1996). "Effects of progestogens on haemostasis". <i>Maturitas</i>. <b>24</b> (1–2): 1–19. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0378-5122%2896%2900994-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0378-5122%2896%2900994-2'" tppabs="https://doi.org/10.1016%2F0378-5122%2896%2900994-2" class="external text external">10.1016/0378-5122(96)00994-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8794429  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8794429'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8794429" class="external text external">8794429</a>.</cite></span></li><li id="cite_note-pmid23384742-54"> <span id="mw-reference-text-cite_note-pmid23384742-54" class="mw-reference-text"><cite id="CITEREFSitruk-WareNath2013" class="citation journal cs1">Sitruk-Ware R, Nath A (February 2013). "Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills". <i>Best Pract. Res. Clin. Endocrinol. Metab</i>. <b>27</b> (1): 13–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.beem.2012.09.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.beem.2012.09.004'" tppabs="https://doi.org/10.1016%2Fj.beem.2012.09.004" class="external text external">10.1016/j.beem.2012.09.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23384742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23384742'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23384742" class="external text external">23384742</a>.</cite></span></li><li id="cite_note-pmid26512437-55"> <span id="mw-reference-text-cite_note-pmid26512437-55" class="mw-reference-text"><cite id="CITEREFNelson2015" class="citation journal cs1">Nelson AL (2015). "An update on new orally administered contraceptives for women". <i>Expert Opin Pharmacother</i>. <b>16</b> (18): 2759–72. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2015.1100173  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2015.1100173'" tppabs="https://doi.org/10.1517%2F14656566.2015.1100173" class="external text external">10.1517/14656566.2015.1100173</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26512437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26512437'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26512437" class="external text external">26512437</a>.</cite></span></li><li id="cite_note-pmid28712325-56"> <span id="mw-reference-text-cite_note-pmid28712325-56" class="mw-reference-text"><cite id="CITEREFFarrisBastianelliRosatoBrosens2017" class="citation journal cs1">Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G (October 2017). "Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis". <i>Expert Rev Clin Pharmacol</i>. <b>10</b> (10): 1129–1144. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F17512433.2017.1356718  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F17512433.2017.1356718'" tppabs="https://doi.org/10.1080%2F17512433.2017.1356718" class="external text external">10.1080/17512433.2017.1356718</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28712325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28712325'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28712325" class="external text external">28712325</a>.</cite></span></li><li id="cite_note-pmid19938948-57"> <span id="mw-reference-text-cite_note-pmid19938948-57" class="mw-reference-text"><cite id="CITEREFSimonciniGenazzani2010" class="citation journal cs1">Simoncini T, Genazzani AR (February 2010). "A review of the cardiovascular and breast actions of drospirenone in preclinical studies". <i>Climacteric</i>. <b>13</b> (1): 22–33. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697130903437375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697130903437375'" tppabs="https://doi.org/10.3109%2F13697130903437375" class="external text external">10.3109/13697130903437375</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19938948  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19938948'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19938948" class="external text external">19938948</a>.</cite></span></li><li id="cite_note-pmid21414337-58"> <span id="mw-reference-text-cite_note-pmid21414337-58" class="mw-reference-text"><cite id="CITEREFAfricanderVerhoogHapgood2011" class="citation journal cs1">Africander D, Verhoog N, Hapgood JP (June 2011). "Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception". <i>Steroids</i>. <b>76</b> (7): 636–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.steroids.2011.03.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.steroids.2011.03.001'" tppabs="https://doi.org/10.1016%2Fj.steroids.2011.03.001" class="external text external">10.1016/j.steroids.2011.03.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21414337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21414337'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21414337" class="external text external">21414337</a>.</cite></span></li><li id="cite_note-pmid27548404-59"> <span id="mw-reference-text-cite_note-pmid27548404-59" class="mw-reference-text"><cite id="CITEREFPalaciosMejía2016" class="citation journal cs1">Palacios S, Mejía A (November 2016). "Progestogen safety and tolerance in hormonal replacement therapy". <i>Expert Opin Drug Saf</i>. <b>15</b> (11): 1515–1525. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F14740338.2016.1223041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F14740338.2016.1223041'" tppabs="https://doi.org/10.1080%2F14740338.2016.1223041" class="external text external">10.1080/14740338.2016.1223041</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27548404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27548404'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27548404" class="external text external">27548404</a>.</cite></span></li><li id="cite_note-pmid26357645-60"> <span id="mw-reference-text-cite_note-pmid26357645-60" class="mw-reference-text"><cite id="CITEREFCaglayanCaglayanAlkisArslan2015" class="citation journal cs1">Caglayan EK, Caglayan K, Alkis I, Arslan E, Okur A, Banli O, Engin-Ustün Y (August 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745" class="external text external">"Factors Associated with Mammographic Density in Postmenopausal Women"</a>. <i>J Menopausal Med</i>. <b>21</b> (2): 82–8. doi:<a href="javascript:if(confirm('https://doi.org/10.6118%2Fjmm.2015.21.2.82  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.6118%2Fjmm.2015.21.2.82'" tppabs="https://doi.org/10.6118%2Fjmm.2015.21.2.82" class="external text external">10.6118/jmm.2015.21.2.82</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561745" class="external text external">4561745</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26357645  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26357645'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26357645" class="external text external">26357645</a>.</cite></span></li><li id="cite_note-pmid31239112-61"> <span id="mw-reference-text-cite_note-pmid31239112-61" class="mw-reference-text"><cite id="CITEREFHirschbergTaniBrismarLundström2019" class="citation journal cs1">Hirschberg AL, Tani E, Brismar K, Lundström E (August 2019). <a href="javascript:if(confirm('https://doi.org/10.1016/j.maturitas.2019.04.205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.maturitas.2019.04.205'" tppabs="https://doi.org/10.1016/j.maturitas.2019.04.205" class="external text external">"Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial"</a>. <i>Maturitas</i>. <b>126</b>: 18–24. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2019.04.205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2019.04.205'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2019.04.205" class="external text external">10.1016/j.maturitas.2019.04.205</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31239112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31239112'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31239112" class="external text external">31239112</a>.</cite></span></li><li id="cite_note-pmid31512725-62"> <span id="mw-reference-text-cite_note-pmid31512725-62" class="mw-reference-text"><cite id="CITEREFTrabertShermanKannanStanczyk2019" class="citation journal cs1">Trabert B, Sherman ME, Kannan N, Stanczyk FZ (September 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851" class="external text external">"Progesterone and breast cancer"</a>. <i>Endocr. Rev</i>. <b>41</b> (2): 320–344. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fendrev%2Fbnz001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fendrev%2Fbnz001'" tppabs="https://doi.org/10.1210%2Fendrev%2Fbnz001" class="external text external">10.1210/endrev/bnz001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851" class="external text external">7156851</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31512725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31512725'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31512725" class="external text external">31512725</a>.</cite></span></li><li id="cite_note-pmid31474332-63"> <span id="mw-reference-text-cite_note-pmid31474332-63" class="mw-reference-text"><cite id="CITEREFCollaborative_Group_on_Hormonal_Factors_in_Breast_Cancer2019" class="citation journal cs1">Collaborative Group on Hormonal Factors in Breast Cancer (September 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893" class="external text external">"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence"</a>. <i>Lancet</i>. <b>394</b> (10204): 1159–1168. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2819%2931709-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2819%2931709-X'" tppabs="https://doi.org/10.1016%2FS0140-6736%2819%2931709-X" class="external text external">10.1016/S0140-6736(19)31709-X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891893" class="external text external">6891893</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31474332  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31474332'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31474332" class="external text external">31474332</a>.</cite></span></li><li id="cite_note-pmid23651281-64"> <span id="mw-reference-text-cite_note-pmid23651281-64" class="mw-reference-text"><cite id="CITEREFSturdee2013" class="citation journal cs1">Sturdee DW (2013). "Are progestins really necessary as part of a combined HRT regimen?". <i>Climacteric</i>. 16 Suppl 1: 79–84. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697137.2013.803311  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697137.2013.803311'" tppabs="https://doi.org/10.3109%2F13697137.2013.803311" class="external text external">10.3109/13697137.2013.803311</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23651281  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23651281'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23651281" class="external text external">23651281</a>.</cite></span></li><li id="cite_note-pmid7625729-65"> <span id="mw-reference-text-cite_note-pmid7625729-65" class="mw-reference-text"><cite id="CITEREFMuhnFuhrmannFritzemeierKrattenmacher1995" class="citation journal cs1">Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E (1995). "Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity". <i>Ann. N. Y. Acad. Sci</i>. <b>761</b> (3): 311–35. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1995NYASA.761..311M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1995NYASA.761..311M'" tppabs="https://ui.adsabs.harvard.edu/abs/1995NYASA.761..311M" class="external text external">1995NYASA.761..311M</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.1995.tb31386.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.1995.tb31386.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.1995.tb31386.x" class="external text external">10.1111/j.1749-6632.1995.tb31386.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7625729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7625729'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7625729" class="external text external">7625729</a>.</cite></span></li><li id="cite_note-FuhrmannKrattenmacher1996-66"> <span id="mw-reference-text-cite_note-FuhrmannKrattenmacher1996-66" class="mw-reference-text"><cite id="CITEREFFuhrmannKrattenmacherSlaterFritzemeier1996" class="citation journal cs1">Fuhrmann, Ulrike; Krattenmacher, Rolf; Slater, Emily P.; Fritzemeier, Karl-Heinrich (1996). "The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential". <i>Contraception</i>. <b>54</b> (4): 243–251. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0010-7824%2896%2900195-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0010-7824%2896%2900195-3'" tppabs="https://doi.org/10.1016%2FS0010-7824%2896%2900195-3" class="external text external">10.1016/S0010-7824(96)00195-3</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8922878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8922878'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8922878" class="external text external">8922878</a>.</cite></span></li><li id="cite_note-pmid23954501-67"> <span id="mw-reference-text-cite_note-pmid23954501-67" class="mw-reference-text"><cite id="CITEREFHapgoodAfricanderLouwRay2014" class="citation journal cs1">Hapgood JP, Africander D, Louw R, Ray RM, Rohwer JM (July 2014). "Potency of progestogens used in hormonal therapy: toward understanding differential actions". <i>J. Steroid Biochem. Mol. Biol</i>. <b>142</b>: 39–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jsbmb.2013.08.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jsbmb.2013.08.001'" tppabs="https://doi.org/10.1016%2Fj.jsbmb.2013.08.001" class="external text external">10.1016/j.jsbmb.2013.08.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23954501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23954501'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23954501" class="external text external">23954501</a>.</cite></span></li><li id="cite_note-pmid30325245-68"> <span id="mw-reference-text-cite_note-pmid30325245-68" class="mw-reference-text"><cite id="CITEREFBastianelliFarrisRosatoBrosens2018" class="citation journal cs1">Bastianelli C, Farris M, Rosato E, Brosens I, Benagiano G (November 2018). "Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation". <i>Expert Rev Clin Pharmacol</i>. <b>11</b> (11): 1085–1098. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F17512433.2018.1536544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F17512433.2018.1536544'" tppabs="https://doi.org/10.1080%2F17512433.2018.1536544" class="external text external">10.1080/17512433.2018.1536544</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30325245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30325245'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30325245" class="external text external">30325245</a>.</cite></span></li><li id="cite_note-pmid22078182-69"> <span id="mw-reference-text-cite_note-pmid22078182-69" class="mw-reference-text"><cite id="CITEREFEndrikatGerlingerRichardRosenbaum2011" class="citation journal cs1">Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B (December 2011). "Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide". <i>Contraception</i>. <b>84</b> (6): 549–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2011.04.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2011.04.009'" tppabs="https://doi.org/10.1016%2Fj.contraception.2011.04.009" class="external text external">10.1016/j.contraception.2011.04.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22078182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22078182'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22078182" class="external text external">22078182</a>.</cite></span></li><li id="cite_note-Kuhl2011-70"> <span id="mw-reference-text-cite_note-Kuhl2011-70" class="mw-reference-text"><cite id="CITEREFKuhl_H2011" class="citation journal cs1">Kuhl H (2011). <a href="javascript:if(confirm('http://www.kup.at/kup/pdf/10168.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.kup.at/kup/pdf/10168.pdf'" tppabs="http://www.kup.at/kup/pdf/10168.pdf" class="external text external">"Pharmacology of Progestogens"</a> <span class="cs1-format">(PDF)</span>. <i>J Reproduktionsmed Endokrinol</i>. <b>8</b> (1): 157–177.</cite></span></li><li id="cite_note-pmid14667981-71"> <span id="mw-reference-text-cite_note-pmid14667981-71" class="mw-reference-text"><cite id="CITEREFElgerBeierPollowGarfield2003" class="citation journal cs1">Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A (November 2003). "Conception and pharmacodynamic profile of drospirenone". <i>Steroids</i>. <b>68</b> (10–13): 891–905. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.steroids.2003.08.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.steroids.2003.08.008'" tppabs="https://doi.org/10.1016%2Fj.steroids.2003.08.008" class="external text external">10.1016/j.steroids.2003.08.008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14667981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14667981'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14667981" class="external text external">14667981</a>.</cite></span></li><li id="cite_note-pmid14670641-72"> <span id="mw-reference-text-cite_note-pmid14670641-72" class="mw-reference-text"><cite id="CITEREFSchindlerCampagnoliDruckmannHuber2003" class="citation journal cs1">Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (December 2003). "Classification and pharmacology of progestins". <i>Maturitas</i>. 46 Suppl 1: S7–S16. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2003.09.014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2003.09.014'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2003.09.014" class="external text external">10.1016/j.maturitas.2003.09.014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14670641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14670641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14670641" class="external text external">14670641</a>.</cite></span></li><li id="cite_note-Drospirenone-73"> <span id="mw-reference-text-cite_note-Drospirenone-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/Drospirenone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/Drospirenone#section=InChI-Key'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/Drospirenone#section=InChI-Key" class="external text external">"Drospirenone"</a>. <i>pubchem.ncbi.nlm.nih.gov</i>.</cite></span></li><li id="cite_note-pmid31446440-74"> <span id="mw-reference-text-cite_note-pmid31446440-74" class="mw-reference-text"><cite id="CITEREFHadjiColliRegidor2019" class="citation journal cs1">Hadji P, Colli E, Regidor PA (December 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087" class="external text external">"Bone health in estrogen-free contraception"</a>. <i>Osteoporos Int</i>. <b>30</b> (12): 2391–2400. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00198-019-05103-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00198-019-05103-6'" tppabs="https://doi.org/10.1007%2Fs00198-019-05103-6" class="external text external">10.1007/s00198-019-05103-6</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203087" class="external text external">7203087</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31446440  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31446440'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31446440" class="external text external">31446440</a>.</cite></span></li><li id="cite_note-CorniaAnawalt2005-75"> <span id="mw-reference-text-cite_note-CorniaAnawalt2005-75" class="mw-reference-text"><cite id="CITEREFCorniaAnawalt2005" class="citation journal cs1">Cornia, Paul B; Anawalt, Bradley D (2005). "Male hormonal contraceptives: a potentially patentable and profitable product". <i>Expert Opinion on Therapeutic Patents</i>. <b>15</b> (12): 1727–1737. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F13543776.15.12.1727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F13543776.15.12.1727'" tppabs="https://doi.org/10.1517%2F13543776.15.12.1727" class="external text external">10.1517/13543776.15.12.1727</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1354-3776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1354-3776'" tppabs="https://www.worldcat.org/issn/1354-3776" class="external text external">1354-3776</a>.</cite></span></li><li id="cite_note-pmid20933120-76"> <span id="mw-reference-text-cite_note-pmid20933120-76" class="mw-reference-text"><cite id="CITEREFNieschlag2010" class="citation journal cs1">Nieschlag E (2010). <a href="javascript:if(confirm('http://www.kup.at/kup/pdf/10172.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.kup.at/kup/pdf/10172.pdf'" tppabs="http://www.kup.at/kup/pdf/10172.pdf" class="external text external">"Clinical trials in male hormonal contraception"</a> <span class="cs1-format">(PDF)</span>. <i>Contraception</i>. <b>82</b> (5): 457–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2010.03.020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2010.03.020'" tppabs="https://doi.org/10.1016%2Fj.contraception.2010.03.020" class="external text external">10.1016/j.contraception.2010.03.020</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20933120  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20933120'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20933120" class="external text external">20933120</a>.</cite></span></li><li id="cite_note-NieschlagBehre2012-77"> <span id="mw-reference-text-cite_note-NieschlagBehre2012-77" class="mw-reference-text"><cite id="CITEREFNieschlagBehreNieschlagBehre2012" class="citation book cs1">Nieschlag, Eberhard; Behre, Hermann M.; Nieschlag, Eberhard; Behre, Hermann M.; Nieschlag, Susan (2012). "The essential role of testosterone in hormonal male contraception".  In Nieschlag, Eberhard; Behre, Hermann M; Nieschlag, Susan (eds.). <i>Testosterone</i>. pp.<span>&nbsp;</span>470–493. doi:<a href="javascript:if(confirm('https://doi.org/10.1017%2FCBO9781139003353.023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2FCBO9781139003353.023'" tppabs="https://doi.org/10.1017%2FCBO9781139003353.023" class="external text external">10.1017/CBO9781139003353.023</a>. ISBN<span>&nbsp;</span><bdi>9781139003353</bdi>.</cite></span></li><li id="cite_note-Stanczyk2007-78"> <span id="mw-reference-text-cite_note-Stanczyk2007-78" class="mw-reference-text"><cite id="CITEREFStanczyk2007" class="citation book cs1">Stanczyk, Frank Z. (2007). "Structure –Function Relationships, Pharmacokinetics, and Potency of Orally and Parenterally Administered Progestogens". <i>Treatment of the Postmenopausal Woman</i>. pp.<span>&nbsp;</span>779–798. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FB978-012369443-0%2F50067-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FB978-012369443-0%2F50067-3'" tppabs="https://doi.org/10.1016%2FB978-012369443-0%2F50067-3" class="external text external">10.1016/B978-012369443-0/50067-3</a>. ISBN<span>&nbsp;</span><bdi>9780123694430</bdi>.</cite></span></li><li id="cite_note-SchneiderNaftolin2004-79"> <span id="mw-reference-text-cite_note-SchneiderNaftolin2004-79" class="mw-reference-text"><cite id="CITEREFHermann_P.G._SchneiderFrederick_Naftolin2004" class="citation book cs1">Hermann P.G. Schneider; Frederick Naftolin (22 September 2004). <a href="javascript:if(confirm('https://books.google.com/books?id=jaOebeNbAkUC&pg=PA133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jaOebeNbAkUC&pg=PA133'" tppabs="https://books.google.com/books?id=jaOebeNbAkUC&pg=PA133" class="external text external"><i>Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society</i></a>. CRC Press. pp.<span>&nbsp;</span>133–. ISBN<span>&nbsp;</span><bdi>978-0-203-02496-6</bdi>.</cite></span></li><li id="cite_note-pmid8616985-80"> <span id="mw-reference-text-cite_note-pmid8616985-80" class="mw-reference-text"><cite id="CITEREFSimon1995" class="citation journal cs1">Simon JA (December 1995). "Micronized progesterone: vaginal and oral uses". <i>Clinical Obstetrics and Gynecology</i>. <b>38</b> (4): 902–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00003081-199538040-00024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00003081-199538040-00024'" tppabs="https://doi.org/10.1097%2F00003081-199538040-00024" class="external text external">10.1097/00003081-199538040-00024</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8616985  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8616985'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8616985" class="external text external">8616985</a>.</cite></span></li><li id="cite_note-Genazzani_2007-81"> <span id="mw-reference-text-cite_note-Genazzani_2007-81" class="mw-reference-text"><cite id="CITEREFGenazzaniMannellaSimoncini2007" class="citation journal cs1">Genazzani, Andrea R.; Mannella, Paolo; Simoncini, Tommaso (February 2007). <a href="javascript:if(confirm('http://www.redorbit.com/news/health/864217/drospirenone_and_its_antialdosterone_properties/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.redorbit.com/news/health/864217/drospirenone_and_its_antialdosterone_properties/'" tppabs="http://www.redorbit.com/news/health/864217/drospirenone_and_its_antialdosterone_properties/" class="external text external">"Drospirenone and its antialdosterone properties"</a>. <i>Climacteric</i>. <b>10</b> (Supplement 1): 11–18. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130601114891  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130601114891'" tppabs="https://doi.org/10.1080%2F13697130601114891" class="external text external">10.1080/13697130601114891</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17364593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17364593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17364593" class="external text external">17364593</a><span class="reference-accessdate">. Retrieved <span class="nowrap">November 26,</span> 2011</span>.</cite></span></li><li id="cite_note-InfanteArmani2019-82"> <span id="mw-reference-text-cite_note-InfanteArmani2019-82" class="mw-reference-text"><cite id="CITEREFInfanteArmaniMarzollaFabbri2019" class="citation journal cs1">Infante, Marco; Armani, Andrea; Marzolla, Vincenzo; Fabbri, Andrea; Caprio, Massimiliano (2019). "Adipocyte Mineralocorticoid Receptor". <i>Vitamins and Hormones</i>. Elsevier. <b>109</b>: 189–209. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fbs.vh.2018.10.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fbs.vh.2018.10.005'" tppabs="https://doi.org/10.1016%2Fbs.vh.2018.10.005" class="external text external">10.1016/bs.vh.2018.10.005</a>. ISBN<span>&nbsp;</span><bdi>9780128177822</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0083-6729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0083-6729'" tppabs="https://www.worldcat.org/issn/0083-6729" class="external text external">0083-6729</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30678856  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30678856'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30678856" class="external text external">30678856</a>.</cite></span></li><li id="cite_note-pmid26965204-83"> <span id="mw-reference-text-cite_note-pmid26965204-83" class="mw-reference-text"><cite id="CITEREFGiordanoFrontiniCinti2016" class="citation journal cs1">Giordano A, Frontini A, Cinti S (June 2016). "Convertible visceral fat as a therapeutic target to curb obesity". <i>Nat Rev Drug Discov</i>. <b>15</b> (6): 405–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrd.2016.31  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrd.2016.31'" tppabs="https://doi.org/10.1038%2Fnrd.2016.31" class="external text external">10.1038/nrd.2016.31</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26965204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26965204'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26965204" class="external text external">26965204</a>.</cite></span></li><li id="cite_note-pmid15669548-84"> <span id="mw-reference-text-cite_note-pmid15669548-84" class="mw-reference-text"><cite id="CITEREFSitruk-WareHusmannThijssenSkouby2004" class="citation journal cs1">Sitruk-Ware R, Husmann F, Thijssen JH, Skouby SO, Fruzzetti F, Hanker J, Huber J, Druckmann R (September 2004). "Role of progestins with partial antiandrogenic effects". <i>Climacteric</i>. <b>7</b> (3): 238–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130400001307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130400001307'" tppabs="https://doi.org/10.1080%2F13697130400001307" class="external text external">10.1080/13697130400001307</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15669548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15669548'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15669548" class="external text external">15669548</a>.</cite></span></li><li id="cite_note-pmid23484104-85"> <span id="mw-reference-text-cite_note-pmid23484104-85" class="mw-reference-text"><cite id="CITEREFYehChangWeiWang2013" class="citation journal cs1">Yeh YT, Chang CW, Wei RJ, Wang SN (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253" class="external text external">"Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects"</a>. <i>Biomed Res Int</i>. <b>2013</b>: 290575. doi:<a href="javascript:if(confirm('https://doi.org/10.1155%2F2013%2F290575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F2013%2F290575'" tppabs="https://doi.org/10.1155%2F2013%2F290575" class="external text external">10.1155/2013/290575</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581253" class="external text external">3581253</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23484104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23484104'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23484104" class="external text external">23484104</a>.</cite></span></li><li id="cite_note-Schindler2015-86"> <span id="mw-reference-text-cite_note-Schindler2015-86" class="mw-reference-text"><cite id="CITEREFSchindler2015" class="citation book cs1">Schindler, Adolf E. (2015). "Hormonal Contraceptives: Progestogen and Thrombotic Risk". <i>Frontiers in Gynecological Endocrinology</i>. ISGE Series. pp.<span>&nbsp;</span>69–75. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-319-09662-9_8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-319-09662-9_8'" tppabs="https://doi.org/10.1007%2F978-3-319-09662-9_8" class="external text external">10.1007/978-3-319-09662-9_8</a>. ISBN<span>&nbsp;</span><bdi>978-3-319-09661-2</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2197-8735  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2197-8735'" tppabs="https://www.worldcat.org/issn/2197-8735" class="external text external">2197-8735</a>.</cite></span></li><li id="cite_note-pmid23758160-87"> <span id="mw-reference-text-cite_note-pmid23758160-87" class="mw-reference-text"><cite id="CITEREFNeubauerMaZhouYu2013" class="citation journal cs1">Neubauer H, Ma Q, Zhou J, Yu Q, Ruan X, Seeger H, Fehm T, Mueck AO (October 2013). "Possible role of PGRMC1 in breast cancer development". <i>Climacteric</i>. <b>16</b> (5): 509–13. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697137.2013.800038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697137.2013.800038'" tppabs="https://doi.org/10.3109%2F13697137.2013.800038" class="external text external">10.3109/13697137.2013.800038</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23758160  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23758160'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23758160" class="external text external">23758160</a>.</cite></span></li><li id="cite_note-NegwerScharnow2001-88"> <span id="mw-reference-text-cite_note-NegwerScharnow2001-88" class="mw-reference-text"><cite id="CITEREFMartin_NegwerHans-Georg_Scharnow2001" class="citation book cs1">Martin Negwer; Hans-Georg Scharnow (4 October 2001). <a href="javascript:if(confirm('https://books.google.com/books?id=1XBqAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=1XBqAAAAMAAJ'" tppabs="https://books.google.com/books?id=1XBqAAAAMAAJ" class="external text external"><i>Organic-chemical drugs and their synonyms: (an international survey)</i></a>. Wiley-VCH. p.<span>&nbsp;</span>2539. ISBN<span>&nbsp;</span><bdi>978-3-527-30247-5</bdi>.</cite></span></li><li id="cite_note-Carp2015-89"> <span id="mw-reference-text-cite_note-Carp2015-89" class="mw-reference-text"><cite id="CITEREFHoward_J.A._Carp2015" class="citation book cs1">Howard J.A. Carp (9 April 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=Ik8SCAAAQBAJ&pg=PA115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Ik8SCAAAQBAJ&pg=PA115'" tppabs="https://books.google.com/books?id=Ik8SCAAAQBAJ&pg=PA115" class="external text external"><i>Progestogens in Obstetrics and Gynecology</i></a>. Springer. pp.<span>&nbsp;</span>115–. ISBN<span>&nbsp;</span><bdi>978-3-319-14385-9</bdi>.</cite></span></li><li id="cite_note-pmid15134800-90"> <span id="mw-reference-text-cite_note-pmid15134800-90" class="mw-reference-text"><cite id="CITEREFMénard2004" class="citation journal cs1">Ménard J (2004). "The 45-year story of the development of an anti-aldosterone more specific than spironolactone". <i>Mol. Cell. Endocrinol</i>. <b>217</b> (1–2): 45–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mce.2003.10.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mce.2003.10.008'" tppabs="https://doi.org/10.1016%2Fj.mce.2003.10.008" class="external text external">10.1016/j.mce.2003.10.008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15134800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15134800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15134800" class="external text external">15134800</a>. <q>[Spironolactone] was synthesized after the demonstration of the natriuretic effect of progesterone (Landau et al., 1955).</q></cite></span></li><li id="cite_note-JamesonGroot2010-91"> <span id="mw-reference-text-cite_note-JamesonGroot2010-91" class="mw-reference-text"><cite id="CITEREFJ._Larry_JamesonLeslie_J._De_Groot2010" class="citation book cs1">J. Larry Jameson; Leslie J. De Groot (18 May 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=W4dZ-URK8ZoC&pg=PA2401  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=W4dZ-URK8ZoC&pg=PA2401'" tppabs="https://books.google.com/books?id=W4dZ-URK8ZoC&pg=PA2401" class="external text external"><i>Endocrinology - E-Book: Adult and Pediatric</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>2401–. ISBN<span>&nbsp;</span><bdi>978-1-4557-1126-0</bdi>. <q>[Spironolactone] is a potent antimineralocorticoid which was developed as a progestational analog [...]</q></cite></span></li><li id="cite_note-Elsevier2019-92"> <span id="mw-reference-text-cite_note-Elsevier2019-92" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5daEDwAAQBAJ&pg=PA46  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5daEDwAAQBAJ&pg=PA46'" tppabs="https://books.google.com/books?id=5daEDwAAQBAJ&pg=PA46" class="external text external"><i>Aldosterone</i></a>. Elsevier Science. 23 January 2019. p.<span>&nbsp;</span>46. ISBN<span>&nbsp;</span><bdi>978-0-12-817783-9</bdi>. <q>In addition to spironolactone, which is a derivative of progesterone [...]</q></cite></span></li><li id="cite_note-pmid16101407-93"> <span id="mw-reference-text-cite_note-pmid16101407-93" class="mw-reference-text"><cite id="CITEREFHuLiMcMahonLala2005" class="citation journal cs1">Hu X, Li S, McMahon EG, Lala DS, Rudolph AE (2005). "Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone". <i>Mini Rev Med Chem</i>. <b>5</b> (8): 709–18. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F1389557054553811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F1389557054553811'" tppabs="https://doi.org/10.2174%2F1389557054553811" class="external text external">10.2174/1389557054553811</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16101407  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16101407'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16101407" class="external text external">16101407</a>.</cite></span></li><li id="cite_note-pmid2744183-94"> <span id="mw-reference-text-cite_note-pmid2744183-94" class="mw-reference-text"><cite id="CITEREFNakajimaBrumstedRiddickGibson1989" class="citation journal cs1">Nakajima ST, Brumsted JR, Riddick DH, Gibson M (1989). "Absence of progestational activity of oral spironolactone". <i>Fertil. Steril</i>. <b>52</b> (1): 155–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0015-0282%2816%2960807-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0015-0282%2816%2960807-5'" tppabs="https://doi.org/10.1016%2Fs0015-0282%2816%2960807-5" class="external text external">10.1016/s0015-0282(16)60807-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2744183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2744183'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2744183" class="external text external">2744183</a>.</cite></span></li><li id="cite_note-pmid13601900-95"> <span id="mw-reference-text-cite_note-pmid13601900-95" class="mw-reference-text"><cite id="CITEREFHertzTullner1958" class="citation journal cs1">Hertz R, Tullner WW (1958). "Progestational activity of certain steroid-17-spirolactones". <i>Proc. Soc. Exp. Biol. Med</i>. <b>99</b> (2): 451–2. doi:<a href="javascript:if(confirm('https://doi.org/10.3181%2F00379727-99-24380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3181%2F00379727-99-24380'" tppabs="https://doi.org/10.3181%2F00379727-99-24380" class="external text external">10.3181/00379727-99-24380</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13601900  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13601900'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13601900" class="external text external">13601900</a>.</cite></span></li><li id="cite_note-96"> <span id="mw-reference-text-cite_note-96" class="mw-reference-text"><span class="citation patent" id="CITEREFMohrNickisch1998"><a href="javascript:if(confirm('https://worldwide.espacenet.com/patent/search/family/007803224/publication/WO9806738A1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/patent/search/family/007803224/publication/WO9806738A1'" tppabs="https://worldwide.espacenet.com/patent/search/family/007803224/publication/WO9806738A1" class="external text external">WO<span> </span>patent 9806738</a>,<span> </span>Mohr, Jörg-Thorsten<span> </span><span>&amp;</span><span> </span>Klaus Nickisch,<span> </span>"PROCESS FOR PRODUCING DROSPIRENONE (6ss,7ss;15ss,16ss-DIMETHYLENE-3-OXO-17 alpha -PREGN-4-EN-21,17-CARBOLACTONE, DRSP), AS WELL AS 7 alpha -(3-HYDROXY-1-PROPYL)-6ss,7ss;15ss,16ss-DIMETHYLENE-5ss-ANDROSTANE-3ss,5,17ss-TRIOL (ZK 92836) AND 6ss,7ss;15ss,16ss-DIMETHYLENE-5ss HYDROXY-5-OXO-17 alpha -ANDROSTANE-21, 17-CARBOLACTONE",<span> </span>issued 1998-02-19,<span> </span> assigned to Shering AG</span></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><span class="citation patent" id="CITEREFMohrNickisch2000"><a href="javascript:if(confirm('https://worldwide.espacenet.com/patent/search/family/007803224/publication/US6121465A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/patent/search/family/007803224/publication/US6121465A'" tppabs="https://worldwide.espacenet.com/patent/search/family/007803224/publication/US6121465A" class="external text external">US<span> </span>patent 6121465</a>,<span> </span>Mohr, Joerg-Thorston<span> </span><span>&amp;</span><span> </span>Klaus Nickisch,<span> </span>"Process for production drospirenone and intermediate products of the process",<span> </span>issued 2000-09-19,<span> </span> assigned to Scheiring AG<span> </span>and Bayer Schering Pharma</span></span></li><li id="cite_note-AdisInsight-EE/DRSP-98"> <span id="mw-reference-text-cite_note-AdisInsight-EE/DRSP-98" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800007379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800007379'" tppabs="https://adisinsight.springer.com/drugs/800007379" class="external text external">"Ethinylestradiol/drospirenone - AdisInsight"</a>.</cite></span></li><li id="cite_note-EE/DRSP/FA-99"> <span id="mw-reference-text-cite_note-EE/DRSP/FA-99" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800032716  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800032716'" tppabs="https://adisinsight.springer.com/drugs/800032716" class="external text external">"Ethinylestradiol/drospirenone/folic acid - AdisInsight"</a>.</cite></span></li><li id="cite_note-EE/DRSP-Low-100"> <span id="mw-reference-text-cite_note-EE/DRSP-Low-100" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800017043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800017043'" tppabs="https://adisinsight.springer.com/drugs/800017043" class="external text external">"Drospirenone/ethinylestradiol low-dose - Bayer HealthCare Pharmaceuticals - AdisInsight"</a>.</cite></span></li><li id="cite_note-E2/DRSP-101"> <span id="mw-reference-text-cite_note-E2/DRSP-101" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800014148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800014148'" tppabs="https://adisinsight.springer.com/drugs/800014148" class="external text external">"Estradiol/drospirenone - Bayer HealthCare Pharmaceuticals - AdisInsight"</a>.</cite></span></li><li id="cite_note-Feeley_2012-102"> <span id="mw-reference-text-cite_note-Feeley_2012-102" class="mw-reference-text"><cite id="CITEREFFeeleyKresge2012" class="citation news cs1">Feeley, Jef; Kresge, Naomi (July 31, 2012). <a href="javascript:if(confirm('https://www.bloomberg.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-6-million.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-6-million.html'" tppabs="https://www.bloomberg.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-6-million.html" class="external text external">"Bayer's Yasmin lawsuit settlements rise to $402.6 million"</a>. <i>Bloomberg News</i>. New York<span class="reference-accessdate">. Retrieved <span class="nowrap">November 11,</span> 2012</span>.</cite></span></li><li id="cite_note-Bayer2015-103"> <span id="mw-reference-text-cite_note-Bayer2015-103" class="mw-reference-text"><cite id="CITEREFAG" class="citation web cs1">AG, Bayer. <a href="javascript:if(confirm('https://www.bayer.com/en/quarterly-reports.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bayer.com/en/quarterly-reports.aspx'" tppabs="https://www.bayer.com/en/quarterly-reports.aspx" class="external text external">"Quarterly Reports of Bayer"</a>. <i>www.bayer.com</i>.</cite></span></li><li id="cite_note-AdisInsight-E4-DRSP-104"> <span id="mw-reference-text-cite_note-AdisInsight-E4-DRSP-104" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800034634  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800034634'" tppabs="https://adisinsight.springer.com/drugs/800034634" class="external text external">"Drospirenone/estetrol - Mithra Pharmaceuticals - AdisInsight"</a>.</cite></span></li><li id="cite_note-AdisInsight-EE-DRSP-DHEA-105"> <span id="mw-reference-text-cite_note-AdisInsight-EE-DRSP-DHEA-105" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800026485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800026485'" tppabs="https://adisinsight.springer.com/drugs/800026485" class="external text external">"Drospirenone/estradiol/prasterone - ANI Pharmaceuticals/Pantarhei Bioscience - AdisInsight"</a>. <i>adisinsight.springer.com</i>.</cite></span></li><li id="cite_note-pmid21729745-106"> <span id="mw-reference-text-cite_note-pmid21729745-106" class="mw-reference-text"><cite id="CITEREFNippeGeneral2011" class="citation journal cs1">Nippe S, General S (September 2011). "Parenteral oil-based drospirenone microcrystal suspensions-evaluation of physicochemical stability and influence of stabilising agents". <i>Int J Pharm</i>. <b>416</b> (1): 181–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijpharm.2011.06.036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijpharm.2011.06.036'" tppabs="https://doi.org/10.1016%2Fj.ijpharm.2011.06.036" class="external text external">10.1016/j.ijpharm.2011.06.036</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21729745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21729745'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21729745" class="external text external">21729745</a>.</cite></span></li><li id="cite_note-pmid22940138-107"> <span id="mw-reference-text-cite_note-pmid22940138-107" class="mw-reference-text"><cite id="CITEREFNippeGeneral2012" class="citation journal cs1">Nippe S, General S (November 2012). "Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release". <i>Eur J Pharm Sci</i>. <b>47</b> (4): 790–800. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejps.2012.08.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejps.2012.08.009'" tppabs="https://doi.org/10.1016%2Fj.ejps.2012.08.009" class="external text external">10.1016/j.ejps.2012.08.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22940138  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22940138'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22940138" class="external text external">22940138</a>.</cite></span></li><li id="cite_note-pmid23116659-108"> <span id="mw-reference-text-cite_note-pmid23116659-108" class="mw-reference-text"><cite id="CITEREFNippePreußeGeneral2013" class="citation journal cs1">Nippe S, Preuße C, General S (February 2013). "Evaluation of the in vitro release and pharmacokinetics of parenteral injectable formulations for steroids". <i>Eur J Pharm Biopharm</i>. <b>83</b> (2): 253–65. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejpb.2012.09.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejpb.2012.09.006'" tppabs="https://doi.org/10.1016%2Fj.ejpb.2012.09.006" class="external text external">10.1016/j.ejpb.2012.09.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23116659  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23116659'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23116659" class="external text external">23116659</a>.</cite></span></li><li id="cite_note-pmid24621345-109"> <span id="mw-reference-text-cite_note-pmid24621345-109" class="mw-reference-text"><cite id="CITEREFNippeGeneral2015" class="citation journal cs1">Nippe S, General S (April 2015). "Investigation of injectable drospirenone organogels with regard to their rheology and comparison to non-stabilized oil-based drospirenone suspensions". <i>Drug Dev Ind Pharm</i>. <b>41</b> (4): 681–91. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F03639045.2014.895375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F03639045.2014.895375'" tppabs="https://doi.org/10.3109%2F03639045.2014.895375" class="external text external">10.3109/03639045.2014.895375</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24621345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24621345'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24621345" class="external text external">24621345</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<div class="div-col columns column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;   ">
<ul><li><cite id="CITEREFKrattenmacher2000" class="citation journal cs1">Krattenmacher R (July 2000). "Drospirenone: pharmacology and pharmacokinetics of a unique progestogen". <i>Contraception</i>. <b>62</b> (1): 29–38. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0010-7824%2800%2900133-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0010-7824%2800%2900133-5'" tppabs="https://doi.org/10.1016%2FS0010-7824%2800%2900133-5" class="external text external">10.1016/S0010-7824(00)00133-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11024226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11024226'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11024226" class="external text external">11024226</a>.</cite></li>
<li><cite id="CITEREFOelkers2000" class="citation journal cs1">Oelkers W (December 2000). "Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone". <i>Eur J Contracept Reprod Health Care</i>. 5 Suppl 3: 17–24. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11246598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11246598'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11246598" class="external text external">11246598</a>.</cite></li>
<li><cite id="CITEREFOelkers2002" class="citation journal cs1">Oelkers W (February 2002). "The renin-aldosterone system and drospirenone". <i>Gynecol. Endocrinol</i>. <b>16</b> (1): 83–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2Fgye.16.1.83.87  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2Fgye.16.1.83.87'" tppabs="https://doi.org/10.1080%2Fgye.16.1.83.87" class="external text external">10.1080/gye.16.1.83.87</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11915587  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11915587'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11915587" class="external text external">11915587</a>.</cite></li>
<li><cite id="CITEREFThorneycroft2002" class="citation journal cs1">Thorneycroft IH (November 2002). "Evolution of progestins. Focus on the novel progestin drospirenone". <i>J Reprod Med</i>. <b>47</b> (11 Suppl): 975–80. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12497671  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12497671'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12497671" class="external text external">12497671</a>.</cite></li>
<li><cite id="CITEREFDickerson2002" class="citation journal cs1">Dickerson V (November 2002). "Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone". <i>J Reprod Med</i>. <b>47</b> (11 Suppl): 985–93. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12497673  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12497673'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12497673" class="external text external">12497673</a>.</cite></li>
<li><cite id="CITEREFOelkers2002" class="citation journal cs1">Oelkers W (December 2002). "Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone". <i>Eur J Contracept Reprod Health Care</i>. 7 Suppl 3: 19–26, discussion 42–3. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12659403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12659403'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12659403" class="external text external">12659403</a>.</cite></li>
<li><cite id="CITEREFRübig2003" class="citation journal cs1">Rübig A (October 2003). "Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties". <i>Climacteric</i>. 6 Suppl 3: 49–54. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15018248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15018248'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15018248" class="external text external">15018248</a>.</cite></li>
<li><cite id="CITEREFOelkers2004" class="citation journal cs1">Oelkers W (March 2004). "Drospirenone, a progestogen with antimineralocorticoid properties: a short review". <i>Mol. Cell. Endocrinol</i>. <b>217</b> (1–2): 255–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mce.2003.10.030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mce.2003.10.030'" tppabs="https://doi.org/10.1016%2Fj.mce.2003.10.030" class="external text external">10.1016/j.mce.2003.10.030</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15134826  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15134826'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15134826" class="external text external">15134826</a>.</cite></li>
<li><cite id="CITEREFHeinemannDinger2004" class="citation journal cs1">Heinemann LA, Dinger J (2004). "Safety of a new oral contraceptive containing drospirenone". <i>Drug Saf</i>. <b>27</b> (13): 1001–18. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-200427130-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-200427130-00003'" tppabs="https://doi.org/10.2165%2F00002018-200427130-00003" class="external text external">10.2165/00002018-200427130-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15471507  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15471507'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15471507" class="external text external">15471507</a>.</cite></li>
<li><cite id="CITEREFKeamWagstaff2003" class="citation journal cs1">Keam SJ, Wagstaff AJ (2003). "Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive". <i>Treat Endocrinol</i>. <b>2</b> (1): 49–70. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00024677-200302010-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00024677-200302010-00005'" tppabs="https://doi.org/10.2165%2F00024677-200302010-00005" class="external text external">10.2165/00024677-200302010-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15871554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15871554'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15871554" class="external text external">15871554</a>.</cite></li>
<li><cite id="CITEREFSitruk-Ware2005" class="citation journal cs1">Sitruk-Ware R (October 2005). "Pharmacology of different progestogens: the special case of drospirenone". <i>Climacteric</i>. 8 Suppl 3: 4–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500330382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500330382'" tppabs="https://doi.org/10.1080%2F13697130500330382" class="external text external">10.1080/13697130500330382</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16203650  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16203650'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16203650" class="external text external">16203650</a>.</cite></li>
<li><cite id="CITEREFOelkers2005" class="citation journal cs1">Oelkers WH (October 2005). "Drospirenone in combination with estrogens: for contraception and hormone replacement therapy". <i>Climacteric</i>. 8 Suppl 3: 19–27. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500330341  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500330341'" tppabs="https://doi.org/10.1080%2F13697130500330341" class="external text external">10.1080/13697130500330341</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16203652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16203652'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16203652" class="external text external">16203652</a>.</cite></li>
<li><cite id="CITEREFFoidart2005" class="citation journal cs1">Foidart JM (October 2005). "Added benefits of drospirenone for compliance". <i>Climacteric</i>. 8 Suppl 3: 28–34. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500330309  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500330309'" tppabs="https://doi.org/10.1080%2F13697130500330309" class="external text external">10.1080/13697130500330309</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16203653  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16203653'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16203653" class="external text external">16203653</a>.</cite></li>
<li><cite id="CITEREFChristiansen2005" class="citation journal cs1">Christiansen C (October 2005). "Effects of drospirenone/estrogen combinations on bone metabolism". <i>Climacteric</i>. 8 Suppl 3: 35–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500330283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500330283'" tppabs="https://doi.org/10.1080%2F13697130500330283" class="external text external">10.1080/13697130500330283</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16203654  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16203654'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16203654" class="external text external">16203654</a>.</cite></li>
<li><cite id="CITEREFWhitehead2006" class="citation journal cs1">Whitehead M (March 2006). "Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data". <i>J Br Menopause Soc</i>. 12 Suppl 1: 4–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1258%2F136218006775992185  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1258%2F136218006775992185'" tppabs="https://doi.org/10.1258%2F136218006775992185" class="external text external">10.1258/136218006775992185</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16513012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16513012'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16513012" class="external text external">16513012</a>.</cite></li>
<li><cite id="CITEREFShulman2006" class="citation journal cs1">Shulman LP (June 2006). "A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone". <i>J Womens Health (Larchmt)</i>. <b>15</b> (5): 584–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fjwh.2006.15.584  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fjwh.2006.15.584'" tppabs="https://doi.org/10.1089%2Fjwh.2006.15.584" class="external text external">10.1089/jwh.2006.15.584</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16796485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16796485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16796485" class="external text external">16796485</a>.</cite></li>
<li><cite id="CITEREFPalaciosFoidartGenazzani2006" class="citation journal cs1">Palacios S, Foidart JM, Genazzani AR (November 2006). <a href="javascript:if(confirm('https://orbi.uliege.be/bitstream/2268/9932/1/Palacios%20S%20M%202006.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://orbi.uliege.be/bitstream/2268/9932/1/Palacios%20S%20M%202006.pdf'" tppabs="https://orbi.uliege.be/bitstream/2268/9932/1/Palacios%20S%20M%202006.pdf" class="external text external">"Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism"</a> <span class="cs1-format">(PDF)</span>. <i>Maturitas</i>. <b>55</b> (4): 297–307. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2006.07.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2006.07.009'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2006.07.009" class="external text external">10.1016/j.maturitas.2006.07.009</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/2268%2F9932  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/2268%2F9932'" tppabs="https://hdl.handle.net/2268%2F9932" class="external text external">2268/9932</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16949774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16949774'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16949774" class="external text external">16949774</a>.</cite></li>
<li><cite id="CITEREFArcher2007" class="citation journal cs1">Archer DF (February 2007). "Drospirenone and estradiol: a new option for the postmenopausal woman". <i>Climacteric</i>. 10 Suppl 1: 3–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130601114859  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130601114859'" tppabs="https://doi.org/10.1080%2F13697130601114859" class="external text external">10.1080/13697130601114859</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17364592  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17364592'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17364592" class="external text external">17364592</a>.</cite></li>
<li><cite id="CITEREFGenazzaniMannellaSimoncini2007" class="citation journal cs1">Genazzani AR, Mannella P, Simoncini T (February 2007). "Drospirenone and its antialdosterone properties". <i>Climacteric</i>. 10 Suppl 1: 11–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130601114891  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130601114891'" tppabs="https://doi.org/10.1080%2F13697130601114891" class="external text external">10.1080/13697130601114891</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17364593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17364593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17364593" class="external text external">17364593</a>.</cite></li>
<li><cite id="CITEREFWhite2007" class="citation journal cs1">White WB (February 2007). "Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension". <i>Climacteric</i>. 10 Suppl 1: 25–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130601114933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130601114933'" tppabs="https://doi.org/10.1080%2F13697130601114933" class="external text external">10.1080/13697130601114933</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17364595  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17364595'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17364595" class="external text external">17364595</a>.</cite></li>
<li><cite id="CITEREFMotivalaPitt2007" class="citation journal cs1">Motivala A, Pitt B (2007). "Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?". <i>Drugs</i>. <b>67</b> (5): 647–55. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200767050-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200767050-00001'" tppabs="https://doi.org/10.2165%2F00003495-200767050-00001" class="external text external">10.2165/00003495-200767050-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17385938  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17385938'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17385938" class="external text external">17385938</a>.</cite></li>
<li><cite id="CITEREFArcher2007" class="citation journal cs1">Archer DF (2007). "Drospirenone, a progestin with added value for hypertensive postmenopausal women". <i>Menopause</i>. <b>14</b> (3 Pt 1): 352–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Fgme.0b013e31804d440b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Fgme.0b013e31804d440b'" tppabs="https://doi.org/10.1097%2Fgme.0b013e31804d440b" class="external text external">10.1097/gme.0b013e31804d440b</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17414576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17414576'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17414576" class="external text external">17414576</a>.</cite></li>
<li><cite id="CITEREFRapkinWiner2007" class="citation journal cs1">Rapkin AJ, Winer SA (May 2007). "Drospirenone: a novel progestin". <i>Expert Opin Pharmacother</i>. <b>8</b> (7): 989–99. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.8.7.989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.8.7.989'" tppabs="https://doi.org/10.1517%2F14656566.8.7.989" class="external text external">10.1517/14656566.8.7.989</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17472544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17472544'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17472544" class="external text external">17472544</a>.</cite></li>
<li><cite id="CITEREFArcher2007" class="citation journal cs1">Archer DF (February 2007). "Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data". <i>J Reprod Med</i>. <b>52</b> (2 Suppl): 159–64. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17477110  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17477110'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17477110" class="external text external">17477110</a>.</cite></li>
<li><cite id="CITEREFMallareddyHanesWhite2007" class="citation journal cs1">Mallareddy M, Hanes V, White WB (2007). "Drospirenone, a new progestogen, for postmenopausal women with hypertension". <i>Drugs Aging</i>. <b>24</b> (6): 453–66. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002512-200724060-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002512-200724060-00002'" tppabs="https://doi.org/10.2165%2F00002512-200724060-00002" class="external text external">10.2165/00002512-200724060-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17571911  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17571911'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17571911" class="external text external">17571911</a>.</cite></li>
<li><cite id="CITEREFFentonWellingtonMoenRobinson2007" class="citation journal cs1">Fenton C, Wellington K, Moen MD, Robinson DM (2007). "Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris". <i>Drugs</i>. <b>67</b> (12): 1749–65. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200767120-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200767120-00007'" tppabs="https://doi.org/10.2165%2F00003495-200767120-00007" class="external text external">10.2165/00003495-200767120-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17683173  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17683173'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17683173" class="external text external">17683173</a>.</cite></li>
<li><cite id="CITEREFScheinfeld2007" class="citation journal cs1">Scheinfeld NS (2007). "Yaz (3 mg drospirenone/20 microg ethinyl estradiol)". <i>Skinmed</i>. <b>6</b> (6): 289. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1540-9740.2007.07338.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1540-9740.2007.07338.x'" tppabs="https://doi.org/10.1111%2Fj.1540-9740.2007.07338.x" class="external text external">10.1111/j.1540-9740.2007.07338.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17975349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17975349'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17975349" class="external text external">17975349</a>.</cite></li>
<li><cite id="CITEREFFoidartFaustmann2007" class="citation journal cs1">Foidart JM, Faustmann T (December 2007). "Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen". <i>Gynecol. Endocrinol</i>. <b>23</b> (12): 692–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F09513590701582323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F09513590701582323'" tppabs="https://doi.org/10.1080%2F09513590701582323" class="external text external">10.1080/09513590701582323</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18075844  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18075844'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18075844" class="external text external">18075844</a>.</cite></li>
<li><cite id="CITEREFRapkinSorgerWiner2008" class="citation journal cs1">Rapkin AJ, Sorger SN, Winer SA (February 2008). "Drospirenone/ethinyl estradiol". <i>Drugs Today</i>. <b>44</b> (2): 133–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1358%2Fdot.2008.44.2.1191057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1358%2Fdot.2008.44.2.1191057'" tppabs="https://doi.org/10.1358%2Fdot.2008.44.2.1191057" class="external text external">10.1358/dot.2008.44.2.1191057</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18389090  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18389090'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18389090" class="external text external">18389090</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:32413831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:32413831'" tppabs="https://api.semanticscholar.org/CorpusID:32413831" class="external text external">32413831</a>.</cite></li>
<li><cite id="CITEREFPérez-López2008" class="citation journal cs1">Pérez-López FR (June 2008). "Clinical experiences with drospirenone: from reproductive to postmenopausal years". <i>Maturitas</i>. <b>60</b> (2): 78–91. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2008.03.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2008.03.009'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2008.03.009" class="external text external">10.1016/j.maturitas.2008.03.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18468818  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18468818'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18468818" class="external text external">18468818</a>.</cite></li>
<li><cite id="CITEREFBitzerPaoletti2009" class="citation journal cs1">Bitzer J, Paoletti AM (2009). "Added benefits and user satisfaction with a low-dose oral contraceptive containing drospirenone: results of three multicentre trials". <i>Clin Drug Investig</i>. <b>29</b> (2): 73–8. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F0044011-200929020-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F0044011-200929020-00001'" tppabs="https://doi.org/10.2165%2F0044011-200929020-00001" class="external text external">10.2165/0044011-200929020-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19133702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19133702'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19133702" class="external text external">19133702</a>.</cite></li>
<li><cite class="citation journal cs1">"Drospirenone in HRT?". <i>Drug Ther Bull</i>. <b>47</b> (4): 41–4. April 2009. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fdtb.2009.03.0011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fdtb.2009.03.0011'" tppabs="https://doi.org/10.1136%2Fdtb.2009.03.0011" class="external text external">10.1136/dtb.2009.03.0011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19357298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19357298'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19357298" class="external text external">19357298</a>.</cite></li>
<li><cite id="CITEREFCarranza-Lira2009" class="citation journal cs1">Carranza-Lira S (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225" class="external text external">"Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review"</a>. <i>Clin Interv Aging</i>. <b>4</b>: 59–62. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FCIA.S4117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FCIA.S4117'" tppabs="https://doi.org/10.2147%2FCIA.S4117" class="external text external">10.2147/CIA.S4117</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685225" class="external text external">2685225</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19503766  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19503766'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19503766" class="external text external">19503766</a>.</cite></li>
<li><cite id="CITEREFSimonciniGenazzani2010" class="citation journal cs1">Simoncini T, Genazzani AR (February 2010). "A review of the cardiovascular and breast actions of drospirenone in preclinical studies". <i>Climacteric</i>. <b>13</b> (1): 22–33. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697130903437375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697130903437375'" tppabs="https://doi.org/10.3109%2F13697130903437375" class="external text external">10.3109/13697130903437375</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19938948  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19938948'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19938948" class="external text external">19938948</a>.</cite></li>
<li><cite id="CITEREFSehovicSmith2010" class="citation journal cs1">Sehovic N, Smith KP (May 2010). "Risk of venous thromboembolism with drospirenone in combined oral contraceptive products". <i>Ann Pharmacother</i>. <b>44</b> (5): 898–903. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1M649  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1M649'" tppabs="https://doi.org/10.1345%2Faph.1M649" class="external text external">10.1345/aph.1M649</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20371756  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20371756'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20371756" class="external text external">20371756</a>.</cite></li>
<li><cite id="CITEREFMachadoPompei_LdeGiribelaGiribela2011" class="citation journal cs1">Machado RB, Pompei Lde M, Giribela AG, Giribela CG (January 2011). <a href="javascript:if(confirm('https://doi.org/10.2217/whe.10.84  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2217/whe.10.84'" tppabs="https://doi.org/10.2217/whe.10.84" class="external text external">"Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits"</a>. <i>Womens Health (Lond)</i>. <b>7</b> (1): 19–30. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2217%2Fwhe.10.84  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2217%2Fwhe.10.84'" tppabs="https://doi.org/10.2217%2Fwhe.10.84" class="external text external">10.2217/whe.10.84</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21175386  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21175386'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21175386" class="external text external">21175386</a>.</cite></li>
<li><cite id="CITEREFRapkinCreinin2011" class="citation journal cs1">Rapkin RB, Creinin MD (October 2011). "The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium". <i>Expert Opin Pharmacother</i>. <b>12</b> (15): 2403–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2011.610791  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2011.610791'" tppabs="https://doi.org/10.1517%2F14656566.2011.610791" class="external text external">10.1517/14656566.2011.610791</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21877996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21877996'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21877996" class="external text external">21877996</a>.</cite></li>
<li><cite id="CITEREFLopezKapteinHelmerhorst2012" class="citation journal cs1">Lopez LM, Kaptein AA, Helmerhorst FM (February 2012). "Oral contraceptives containing drospirenone for premenstrual syndrome". <i>Cochrane Database Syst Rev</i> (2): CD006586. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD006586.pub4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD006586.pub4'" tppabs="https://doi.org/10.1002%2F14651858.CD006586.pub4" class="external text external">10.1002/14651858.CD006586.pub4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22336820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22336820'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22336820" class="external text external">22336820</a>.</cite></li>
<li><cite id="CITEREFWuGrandiFilionAbenhaim2013" class="citation journal cs1">Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ (June 2013). "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review". <i>BJOG</i>. <b>120</b> (7): 801–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2F1471-0528.12210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2F1471-0528.12210'" tppabs="https://doi.org/10.1111%2F1471-0528.12210" class="external text external">10.1111/1471-0528.12210</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23530659  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23530659'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23530659" class="external text external">23530659</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:206904730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:206904730'" tppabs="https://api.semanticscholar.org/CorpusID:206904730" class="external text external">206904730</a>.</cite></li>
<li><cite id="CITEREFToniNeubertBotzenhardtGratzki2013" class="citation journal cs1">Toni I, Neubert A, Botzenhardt S, Gratzki N, Rascher W (September 2013). "Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports". <i>Klin Padiatr</i>. <b>225</b> (5): 266–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1055%2Fs-0033-1353169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1055%2Fs-0033-1353169'" tppabs="https://doi.org/10.1055%2Fs-0033-1353169" class="external text external">10.1055/s-0033-1353169</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23975850  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23975850'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23975850" class="external text external">23975850</a>.</cite></li>
<li><cite id="CITEREFHanJensen2014" class="citation journal cs1">Han L, Jensen JT (October 2014). "Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive". <i>Expert Opin Pharmacother</i>. <b>15</b> (14): 2071–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2014.949237  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2014.949237'" tppabs="https://doi.org/10.1517%2F14656566.2014.949237" class="external text external">10.1517/14656566.2014.949237</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25186109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25186109'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25186109" class="external text external">25186109</a>.</cite></li>
<li><cite id="CITEREFIdotaKobayashiMiyamoriKakiuchi2015" class="citation journal cs1">Idota N, Kobayashi M, Miyamori D, Kakiuchi Y, Ikegaya H (March 2015). "Drospirenone detected in postmortem blood of a young woman with pulmonary thromboembolism: A case report and review of the literature". <i>Leg Med (Tokyo)</i>. <b>17</b> (2): 109–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.legalmed.2014.10.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.legalmed.2014.10.001'" tppabs="https://doi.org/10.1016%2Fj.legalmed.2014.10.001" class="external text external">10.1016/j.legalmed.2014.10.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25454533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25454533'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25454533" class="external text external">25454533</a>.</cite></li>
<li><cite id="CITEREFLeteChabbert-BuffetJaminLello2015" class="citation journal cs1">Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A (2015). "Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review". <i>Eur J Contracept Reprod Health Care</i>. <b>20</b> (5): 329–43. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13625187.2015.1050091  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13625187.2015.1050091'" tppabs="https://doi.org/10.3109%2F13625187.2015.1050091" class="external text external">10.3109/13625187.2015.1050091</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26007631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26007631'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26007631" class="external text external">26007631</a>.</cite></li>
<li><cite id="CITEREFZhaoZhangZhaoLin2016" class="citation journal cs1">Zhao X, Zhang XF, Zhao Y, Lin X, Li NY, Paudel G, Wang QY, Zhang XW, Li XL, Yu J (September 2016). "Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis". <i>Gynecol. Endocrinol</i>. <b>32</b> (9): 685–689. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F09513590.2016.1183629  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F09513590.2016.1183629'" tppabs="https://doi.org/10.1080%2F09513590.2016.1183629" class="external text external">10.1080/09513590.2016.1183629</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27176003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27176003'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27176003" class="external text external">27176003</a>.</cite></li>
<li><cite id="CITEREFBaturCasey2017" class="citation journal cs1">Batur P, Casey PM (February 2017). "Drospirenone Litigation: Does the Punishment Fit the Crime?". <i>J Womens Health (Larchmt)</i>. <b>26</b> (2): 99–102. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fjwh.2016.6092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fjwh.2016.6092'" tppabs="https://doi.org/10.1089%2Fjwh.2016.6092" class="external text external">10.1089/jwh.2016.6092</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27854556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27854556'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27854556" class="external text external">27854556</a>.</cite></li>
<li><cite id="CITEREFLiRenSun2017" class="citation journal cs1">Li J, Ren J, Sun W (March 2017). "A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome". <i>Eur. J. Obstet. Gynecol. Reprod. Biol</i>. <b>210</b>: 13–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejogrb.2016.11.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejogrb.2016.11.013'" tppabs="https://doi.org/10.1016%2Fj.ejogrb.2016.11.013" class="external text external">10.1016/j.ejogrb.2016.11.013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27923166  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27923166'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27923166" class="external text external">27923166</a>.</cite></li>
<li><cite id="CITEREFLarivéeSuissaKhosrow-KhavarTagalakis2017" class="citation journal cs1">Larivée N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB (September 2017). <a href="javascript:if(confirm('https://doi.org/10.1111/1471-0528.14623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/1471-0528.14623'" tppabs="https://doi.org/10.1111/1471-0528.14623" class="external text external">"Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies"</a>. <i>BJOG</i>. <b>124</b> (10): 1490–1499. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2F1471-0528.14623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2F1471-0528.14623'" tppabs="https://doi.org/10.1111%2F1471-0528.14623" class="external text external">10.1111/1471-0528.14623</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28276140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28276140'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28276140" class="external text external">28276140</a>.</cite></li></ul>
</div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf" class="external text external">Slynd (drospirenone) Label</a></li>
<li><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf" class="external text external">Yaz (ethinylestradiol/drospirenone) Label</a></li>
<li><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf" class="external text external">Angeliq (estradiol/drospirenone) Label</a></li>
<li><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800053493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800053493'" tppabs="https://adisinsight.springer.com/drugs/800053493" class="external text external">Drospirenone (Slynd) - AdisInsight</a></li>
<li><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800007379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800007379'" tppabs="https://adisinsight.springer.com/drugs/800007379" class="external text external">Ethinylestradiol/drospirenone (Yasmin) - AdisInsight</a></li>
<li><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800014148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800014148'" tppabs="https://adisinsight.springer.com/drugs/800014148" class="external text external">Estradiol/drospirenone (Angeliq) - AdisInsight</a></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Medical_uses" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Medical_uses" style="font-size:114%;margin:0 4em">Medical uses</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Progestogens_and_antiprogestogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progestogens_and_antiprogestogens" style="font-size:114%;margin:0 4em">Progestogens and antiprogestogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Progestogens<br>(and progestins)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="PR_agonists" scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> Progesterone</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> <a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Hydroxyprogesterone (and closely related) derivatives:</i> <i>17α-Hydroxylated:</i> Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone acetophenide (dihydroxyprogesterone acetophenide)</li>
<li>Anagestone acetate</li>
<li>Chlormadinone acetate</li>
<li>Chlormethenmadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Flugestone acetate (flurogestone acetate)</li>
<li>Flumedroxone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate</li>
<li>Hydroxyprogesterone heptanoate</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a><sup>#</sup></li>
<li>Megestrol acetate</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone acetate</li>
<li>Osaterone acetate</li>
<li>Pentagestrone acetate</li>
<li>Proligestone; <i>17α-Methylated:</i> Medrogestone; <i>Others:</i> Haloprogesterone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> <i>17α-Hydroxylated:</i> Gestonorone caproate (gestronol hexanoate)</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>Segesterone acetate (nestorone, elcometrine); <i>17α-Methylated:</i> Demegestone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> <i>Estranes:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Dimethisterone</li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> <i>Estranes:</i> <a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Dienogest</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Lynestrenol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a><sup>#</sup></li>
<li>Norethisterone acetate</li>
<li>Norethisterone enanthate</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li>Norgestrienone</li>
<li>Normethandrone (methylestrenolone)</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol acetate</li>
<li>Tibolone; <i>Gonanes:</i> <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a><sup>#</sup></li>
<li>Norelgestromin</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li></ul>

<ul><li><i>Spirolactone derivatives:</i> <a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li></ul>

<ul><li><i>Others:</i> Anabolic–androgenic steroids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, trenbolone and esters, <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">ethylestrenol</a>, norethandrolone, others)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiprogestogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>SPRMs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Telapristone<sup>§</sup></li>
<li>Ulipristal acetate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aglepristone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Progesterone receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>List of progestogens</dd></dl></div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Mineralocorticoids_and_antimineralocorticoids_(H02)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Mineralocorticoids_and_antimineralocorticoids_(H02)" style="font-size:114%;margin:0 4em">Mineralocorticoids and antimineralocorticoids (H02)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Mineralocorticoids</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Desoxycortone (desoxycorticosterone)
<ul><li>Desoxycortone esters</li></ul></li>
<li>Hydrocortisone (cortisol)
<ul><li>Hydrocortisone esters</li></ul></li>
<li><a href="Fludrocortisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludrocortisone" title="Fludrocortisone">Fludrocortisone</a>
<ul><li>Fludrocortisone acetate</li></ul></li>
<li><a href="Methylprednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a>
<ul><li>Methylprednisolone esters</li></ul></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a>
<ul><li>Prednisolone esters</li></ul></li>
<li><a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">Prednisone</a>
<ul><li>Prednisone esters</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antimineralocorticoids</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Canrenoate potassium (potassium canrenoate)</li>
<li>Canrenone</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li><a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li><a href="Eplerenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Eplerenone" title="Eplerenone">Eplerenone</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li>Medrogestone</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Trimegestone</li></ul>

<ul><li><i>Nonsteroidal:</i> <a href="Amlodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amlodipine" title="Amlodipine">Amlodipine</a></li>
<li>Apararenone<sup>§</sup></li>
<li>Benidipine</li>
<li>Esaxerenone<sup>†</sup></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li>Finerenone<sup>†</sup></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li><a href="Nimodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimodipine" title="Nimodipine">Nimodipine</a></li>
<li><a href="Nitrendipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Synthesis modifiers</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acetoxolone</li>
<li><a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="Carbenoxolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbenoxolone" title="Carbenoxolone">Carbenoxolone</a></li>
<li>Enoxolone</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Metyrapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="Mitotane.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitotane" title="Mitotane">Mitotane</a></li>
<li><a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Mineralocorticoid receptor modulators</dd>
<dd>Glucocorticoids and antiglucocorticoids</dd>
<dd>List of corticosteroids</dd></dl></div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em">Androgens and antiandrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Androgens<br>(incl. <abbr>AAS</abbr>)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> Androstenediol dipropionate</li>
<li>Boldenone undecylenate</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a></li>
<li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li>
<li>Cloxotestosterone acetate</li>
<li>Prasterone (dehydroepiandrosterone, DHEA)</li>
<li>Prasterone enanthate (DHEA enanthate)</li>
<li>Prasterone sulfate (DHEA sulfate)</li>
<li>Quinbolone</li>
<li>Testosterone<sup>#</sup></li>
<li>Testosterone esters (e.g., testosterone cypionate, testosterone enanthate, testosterone propionate, testosterone undecanoate, testosterone ester mixtures (Deposterona, Omnadren, Sustanon, Testoviron Depot))</li></ul>

<ul><li><i>Dihydrotestosterone derivatives:</i> Androstanolone (stanolone, dihydrotestosterone, DHT)</li>
<li>Androstanolone esters</li>
<li>Bolazine capronate</li>
<li>Drostanolone propionate (dromostanolone propionate)</li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a></li>
<li>Metenolone acetate (methenolone acetate)</li>
<li>Metenolone enanthate (methenolone enanthate)</li>
<li>Stenbolone acetate</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> Bolandiol dipropionate</li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norclostebol</li>
<li>Norclostebol acetate</li>
<li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li>
<li>Trenbolone acetate</li>
<li>Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Metandienone (methandienone, methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)</li>
<li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li>
<li>Methyltestosterone 3-hexyl ether</li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone (thiomesterone)</li></ul>

<ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Mibolerone</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li>Propetandrol (propethandrol)</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li>Progestins (e.g., <a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, lynestrenol, norgestrienone)</li>
<li>Tibolone</li></ul>

<ul><li><i>Progesterone derivatives:</i> <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiestrogens (e.g., <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a>)</li>
<li>GnRH agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>, <a href="Human_chorionic_gonadotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr>hCG</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Abiraterone acetate</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Nomegestrol acetate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Apalutamide</li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Darolutamide</li>
<li>Enzalutamide</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li>Topilutamide (fluridil)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Steroidogenesis<br>inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5α-Reductase</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abiraterone acetate</li>
<li><a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li>Bifluranol</li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., bifluranol, <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>, estradiol esters, ethinylestradiol, ethinylestradiol sulfonate, paroxypropione)</li>
<li>GnRH agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>GnRH antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li>
<li>Progestogens (incl., chlormadinone acetate, cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Androgen receptor modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of androgens/anabolic steroids</dd></dl></div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Pharmacodynamics" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Pharmacodynamics" style="font-size:114%;margin:0 4em">Pharmacodynamics</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Androgen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgen_receptor_modulators" style="font-size:114%;margin:0 4em">Androgen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>AR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> <a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li>4-Dehydroepiandrosterone (4-DHEA)</li>
<li>4-Hydroxytestosterone</li>
<li><span class="new">4,17α-Dimethyltestosterone</span></li>
<li>5-Androstenedione</li>
<li>11-Ketotestosterone</li>
<li>11β-Hydroxyandrostenedione</li>
<li><a href="Adrenosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrenosterone" title="Adrenosterone">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">Androstenediol (5-androstenediol)</a>
<ul><li>Androstenediol 3β-acetate</li>
<li>Androstenediol 17β-acetate</li>
<li>Androstenediol diacetate</li>
<li>Androstenediol dipropionate</li></ul></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">Androstenedione (4-androstenedione)</a></li>
<li>Atamestane</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Boldenone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Boldenone'" tppabs="https://ptable.com/wiki/compounds/A/Boldenone" title="Boldenone">Boldenone</a>
<ul><li>Boldenone undecylenate</li></ul></li>
<li>Boldione (1,4-androstadienedione)</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a>
<ul><li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li></ul></li>
<li>Cloxotestosterone
<ul><li>Cloxotestosterone acetate</li></ul></li>
<li>Dehydroandrosterone</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA (androstenolone, prasterone; 5-DHEA)</a>
<ul><li>DHEA enanthate (prasterone enanthate)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA sulfate</a></li></ul></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li>
<li>Plomestane</li>
<li>Quinbolone</li>
<li>Silandrone</li>
<li>Testosterone<sup>#</sup> (+dutasteride)
<ul><li>Testosterone esters</li>
<li>Polytestosterone phloretin phosphate</li></ul></li></ul>

<ul><li><i>5α-Dihydrotestosterone derivatives:</i> 1-Androstenediol</li>
<li>1-Androstenedione</li>
<li>1-Androsterone (1-andro, 1-DHEA)</li>
<li>1-Testosterone</li>
<li>3α-Androstanediol</li>
<li>5α-Androst-2-en-17-one</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>11-Ketodihydrotestosterone</li>
<li><a href="Androsterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Androsterone" title="Androsterone">Androsterone</a></li>
<li>Bolazine
<ul><li>Bolazine capronate</li></ul></li>
<li><span class="new">Dihydroethyltestosterone</span></li>
<li>Dihydrofluoxymesterone</li>
<li><span class="new">Dihydromethylandrostenediol</span></li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone (DHT)</a> (androstanolone, stanolone)
<ul><li>Dihydrotestosterone esters</li></ul></li>
<li><a href="Drostanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drostanolone" title="Drostanolone">Drostanolone</a>
<ul><li>Drostanolone propionate</li></ul></li>
<li><a href="Epiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Epiandrosterone" title="Epiandrosterone">Epiandrosterone</a></li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li>Mesabolone</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a>
<ul><li>Mesterolone cipionate</li></ul></li>
<li>Methyldiazinol</li>
<li>Nisterime
<ul><li>Nisterime acetate</li></ul></li>
<li>Prostanozol</li>
<li>Stenbolone
<ul><li>Stenbolone acetate</li></ul></li>
<li>Testifenon (testiphenon, testiphenone)</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> 7α-Methyl-19-norandrostenedione (MENT dione, trestione)</li>
<li>11β-Methyl-19-nortestosterone
<ul><li>11β-Methyl-19-nortestosterone dodecylcarbonate</li></ul></li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol
<ul><li>Bolandiol dipropionate</li></ul></li>
<li>Bolandione (19-nor-4-androstenedione)</li>
<li>Bolmantalate (nandrolone adamantoate)</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone
<ul><li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li></ul></li>
<li>LS-1727 (nandrolone 17β-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</li>
<li>Methoxydienone (methoxygonadiene)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a>
<ul><li>Nandrolone esters</li></ul></li>
<li>Norclostebol
<ul><li>Norclostebol acetate</li></ul></li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li><a href="Oxabolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone" title="Oxabolone">Oxabolone</a>
<ul><li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li>
<li>Trenbolone
<ul><li>Trenbolone acetate</li>
<li>Trenbolone enanthate</li>
<li>Trenbolone hexahydrobenzylcarbonate</li>
<li>Trenbolone undecanoate</li></ul></li>
<li>Trendione</li>
<li>Trestolone (MENT)
<ul><li>Trestolone acetate</li>
<li>Trestolone enanthate</li></ul></li></ul>

<ul><li><i>5α-Dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronandrolone</li>
<li><span class="new">5α-Dihydrotrestolone</span></li>
<li>19-Norandrosterone</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethylandrostenediol (CDMA)</li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li>Chloromethylandrostenediol (CMA)</li>
<li>Enestebol</li>
<li>Ethyltestosterone</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Hydroxystenozole</li>
<li>Metandienone (methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)
<ul><li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol diacetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li></ul></li>
<li>Methylclostebol (chloromethyltestosterone)</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a> (+esterified estrogens)
<ul><li>Methyltestosterone 3-hexyl ether</li></ul></li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li>Desoxymethyltestosterone</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li>Metenolone
<ul><li>Metenolone acetate</li>
<li>Metenolone enanthate</li></ul></li>
<li>Methasterone</li>
<li>Methyl-1-testosterone</li>
<li>Methylepitiostanol</li>
<li>Methylstenbolone</li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> Bolenol</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Methyldienolone</li>
<li>Methylhydroxynandrolone (MOHN, MHN)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></li>
<li>Mibolerone</li>
<li>Norboletone</li>
<li>Norethandrolone</li>
<li>Propetandrol</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronorethandrolone</li>
<li>5α-Dihydronormethandrone</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Vinyl-19-nortestosterone derivatives:</i> Vinyltestosterone</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone (ethynyltestosterone)</a></li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyltestosterone derivatives:</i> 17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>Dihydroethisterone</li></ul>

<ul><li><i>17α-Ethynyl-19-nortestosterone derivatives:</i> Δ<sup>4</sup>-Tibolone</li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol
<ul><li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li></ul></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol
<ul><li>Lynestrenol phenylpropionate</li></ul></li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Quingestanol
<ul><li>Quingestanol acetate</li></ul></li>
<li>Tibolone</li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyl-19-nortestosterone derivatives:</i> 5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li></ul>

<ul><li><i>Progesterone derivatives:</i> 6α-Methylprogesterone</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Megestrol acetate</li></ul>

<ul><li><i>Others/unsorted:</i> 3-Keto-5α-abiraterone</li>
<li><a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Androstane" title="5α-Androstane" class="mw-redirect">5α-Androstane</a></li>
<li>Alternariol</li>
<li>Cl-4AS-1</li>
<li>Drupanol</li>
<li><a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li>
<li>ZM-182345</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SARMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nonsteroidal:</i> <span class="new">198RL26</span></li>
<li><span class="new">ACP-105</span></li>
<li><span class="new">AC-262536</span></li>
<li>Acetothiolutamide</li>
<li>Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</li>
<li><span class="new">BMS-564929</span></li>
<li><span class="new">DTIB</span></li>
<li>Enobosarm (ostarine, MK-2866, GTx-024, S-22)</li>
<li><span class="new">FTBU-1</span></li>
<li>GSK2881078</li>
<li><span class="new">GSK-4336A</span></li>
<li><span class="new">GSK-8698</span></li>
<li>LG-121071 (LGD-121071)</li>
<li>LGD-2226</li>
<li><span class="new">LGD-2941 (LGD-122941)</span></li>
<li>LGD-3303</li>
<li>LGD-4033</li>
<li>LY-2452473</li>
<li><span class="new">JNJ-26146900</span></li>
<li>JNJ-28330835</li>
<li><span class="new">JNJ-37654032</span></li>
<li><span class="new">ORM-11984</span></li>
<li><span class="new">R-1</span></li>
<li>RAD140</li>
<li>RU-59063</li>
<li><span class="new">S-1</span></li>
<li>S-23</li>
<li>S-40503</li>
<li><span class="new">S-101479</span></li>
<li>Triclosan</li></ul>

<ul><li><i>Steroidal:</i> <span class="new">EM-9017</span></li>
<li>MK-0773</li>
<li>TFM-4AS-1</li>
<li>YK-11</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 7α-Thioprogesterone</li>
<li>7α-Thiospironolactone</li>
<li>7α-Thiomethylspironolactone</li>
<li>11α-Hydroxyprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Allyltestosterone</li>
<li>Benorterone</li>
<li>BOMT</li>
<li>Canrenoic acid</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Clascoterone</li>
<li>Clometerone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Cyproterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproterone" title="Cyproterone">Cyproterone</a></li>
<li>Cyproterone acetate</li>
<li>Delanterone</li>
<li>Delmadinone acetate</li>
<li>Dicirenone</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>DU-41165</li>
<li>Edogestrone</li>
<li><span class="new">EM-4350</span></li>
<li>EM-5854</li>
<li><span class="new">EM-5855</span></li>
<li><span class="new">EM-6537</span></li>
<li>Epitestosterone</li>
<li>Galeterone</li>
<li>Guggulsterone</li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Mespirenone</li>
<li>Metogest</li>
<li>Mexrenone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>Nomegestrol acetate</li>
<li>Nordinone</li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Prorenone</li>
<li>Rosterolone</li>
<li><span class="new">RU-15328</span></li>
<li>SC-5233 (spirolactone)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li>
<li>Spiroxasone</li>
<li>Topterone</li>
<li>Trimegestone</li>
<li>Trimethyltrienolone (R-2956)</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> 5<i>N</i>-Bicalutamide</li>
<li>AA560</li>
<li><span class="new">Antarlides</span></li>
<li><span class="new">Arabilin</span></li>
<li>Apalutamide</li>
<li>Atraric acid</li>
<li><span class="new">AZD-3514</span></li>
<li>Bakuchiol</li>
<li><span class="new">BAY-1024767</span></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">Bisphenols</a> (e.g., <a href="Bisphenol_A_diglycidyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a>, <span class="new">BFDGE</span>, <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, bisphenol F, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">bisphenol S</a>)</li>
<li><span class="new">BMS-501949</span></li>
<li><span class="new">BMS-570511</span></li>
<li>BMS-641988</li>
<li><span class="new">CH5137291</span></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Cioteronel</li>
<li>Cyanonilutamide</li>
<li>Darolutamide</li>
<li>DDT (via metabolite p,p’-DDE)</li>
<li><a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">Dieldrin</a></li>
<li>DIMP</li>
<li><a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">Endosulfan</a></li>
<li>Enzalutamide</li>
<li>EPI-001</li>
<li>EPI-7386</li>
<li><a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">Fenarimol</a></li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li>Hydroxyflutamide</li>
<li>Inocoterone</li>
<li>Inocoterone acetate</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Ketodarolutamide</li>
<li>Lavender oil</li>
<li><span class="new">LG-105</span></li>
<li>LG-120907</li>
<li><span class="new">LGD-1331</span></li>
<li>Linuron</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><span class="new"><i>N</i>-Butylbenzenesulfonamide</span></li>
<li><i>N</i>-Desmethylapalutamide</li>
<li><i>N</i>-Desmethylenzalutamide</li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><span class="new">ONC1-13B</span></li>
<li>Pentomone</li>
<li><span class="new">PF-998425</span></li>
<li><a href="Phenothrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenothrin" title="Phenothrin">Phenothrin</a></li>
<li>Prochloraz</li>
<li><a href="Procymidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Procymidone" title="Procymidone">Procymidone</a></li>
<li>Proxalutamide</li>
<li>Ralaniten (EPI-002)</li>
<li>Ralaniten acetate (EPI-506)</li>
<li>RD-162</li>
<li><span class="new">Ro 2-7239</span></li>
<li><span class="new">Ro 5-2537</span></li>
<li>RU-22930</li>
<li>RU-56187</li>
<li>RU-57073</li>
<li>RU-58642</li>
<li>RU-58841</li>
<li>Seviteronel</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li>Topilutamide (fluridil)</li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li>Vinclozolin</li>
<li><span class="new">YM-580</span></li>
<li><span class="new">YM-92088</span></li>
<li><span class="new">YM-175735</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPRC6A</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cations (incl. aluminum, <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a>, <a href="Gadolinium.htm" tppabs="https://ptable.com/wiki/compounds/A/Gadolinium" title="Gadolinium">gadolinium</a>, <a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">magnesium</a>, <a href="Strontium.htm" tppabs="https://ptable.com/wiki/compounds/A/Strontium" title="Strontium">strontium</a>, <a href="Zinc.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc" title="Zinc">zinc</a>)</li>
<li>Dehydroandrosterone</li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li><small>L</small>-α-Amino acids (incl. <a href="Arginine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arginine" title="Arginine"><small>L</small>-arginine</a>, <a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine"><small>L</small>-lysine</a>, <a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine"><small>L</small>-ornithine</a>)</li>
<li>Osteocalcin</li>
<li><abbr>SHBG</abbr></li>
<li><a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of androgens/anabolic steroids</dd></dl>
</div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Mineralocorticoid_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Mineralocorticoid_receptor_modulators" style="font-size:114%;margin:0 4em">Mineralocorticoid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>MR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
<ul><li><span class="new">11-Dehydrocorticosterone acetate</span></li></ul></li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone (desoxycortone, deoxycortone, desoxycorticosterone)</a>
<ul><li>Desoxycortone esters</li></ul></li>
<li>11-Deoxycortisol (cortodoxone, cortexolone)
<ul><li>Cortifen (cortiphen, kortifen)</li>
<li><span class="new">Cortodoxone acetate</span></li></ul></li>
<li>11β-Hydroxyprogesterone</li>
<li><span class="new">16α,18-Dihydroxy-11-deoxycorticosterone</span></li>
<li><span class="new">17α-Hydroxyaldosterone</span></li>
<li><span class="new">18-Hydroxy-11-deoxycorticosterone</span></li>
<li>19-Norprogesterone</li>
<li><a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">Aldosterone</a></li>
<li><a href="Corticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Corticosterone" title="Corticosterone">Corticosterone</a>
<ul><li><span class="new">Corticosterone acetate</span></li>
<li><span class="new">Corticosterone benzoate</span></li></ul></li>
<li><a href="Cortisol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cortisol" title="Cortisol">Cortisol</a> (hydrocortisone)
<ul><li>Benzodrocortisone (hydrocortisone benzoate)</li>
<li><a href="Hydrocortamate.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocortamate" title="Hydrocortamate">Hydrocortamate (hydrocortisone diethylaminoacetate)</a></li>
<li>Hydrocortisone esters</li></ul></li>
<li><a href="Cortisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cortisone" title="Cortisone">Cortisone</a>
<ul><li>Cortisone acetate</li></ul></li>
<li><a href="Fludrocortisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludrocortisone" title="Fludrocortisone">Fludrocortisone (fludrocortone)</a>
<ul><li>Fludrocortisone acetate</li></ul></li>
<li>Mometasone
<ul><li><a href="Mometasone_furoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Mometasone_furoate" title="Mometasone furoate" class="mw-redirect">Mometasone furoate</a></li></ul></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a>
<ul><li>Prednazate</li>
<li>Prednazoline</li>
<li><a href="Prednicarbate.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednicarbate" title="Prednicarbate">Prednicarbate (prednisolone ethylcarbonate propionate)</a></li>
<li><a href="Prednimustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednimustine" title="Prednimustine">Prednimustine</a></li>
<li>Prednisolamate (prednisolone diethylaminoacetate)</li>
<li>Prednisolone esters</li></ul></li>
<li><a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">Prednisone</a>
<ul><li>Prednisone esters</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 6β-Hydroxy-7α-thiomethylspironolactone</li>
<li><span class="new">7α-Acetylthio-17α-hydroxyprogesterone</span></li>
<li>7α-Thiomethylspironolactone (SC-26519)</li>
<li>7α-Thioprogesterone (SC-8365)</li>
<li>7α-Thiospironolactone (SC-24813)</li>
<li>16α-Hydroxyprogesterone</li>
<li>17α-Hydroxyprogesterone (hydroxyprogesterone)</li>
<li>18-Deoxyaldosterone</li>
<li><span class="new">18,19-Dinorprogesterone</span></li>
<li>Canrenoate potassium (potassium canrenoate)</li>
<li>Canrenoic acid (canrenoate)</li>
<li>Canrenone (canrenoate y-lactone)</li>
<li>Dicirenone</li>
<li>Dimethisterone</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li><a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li><a href="Eplerenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Eplerenone" title="Eplerenone">Eplerenone</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li>Guggulsterone</li>
<li>Hydroxyprogesterone caproate</li>
<li>Medrogestone</li>
<li>Mespirenone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></li>
<li>Mexrenoate potassium</li>
<li>Mexrenoic acid (mexrenoate)</li>
<li>Mexrenone</li>
<li>Oxprenoic acid (oxprenoate)</li>
<li>Oxprenoate potassium (RU-28318)</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Prorenoate potassium</li>
<li>Prorenoic acid (prorenoate)</li>
<li>Prorenone</li>
<li><span class="new">RO-14-9012</span></li>
<li><span class="new">RU-26752</span></li>
<li>SC-5233 (spirolactone)</li>
<li>SC-8109</li>
<li><span class="new">SC-11927 (CS-1)</span></li>
<li><span class="new">SC-19886</span></li>
<li><span class="new">SC-27169</span></li>
<li>Spirorenone</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spiroxasone</li>
<li>Tibolone</li>
<li>Trimegestone</li>
<li><span class="new">ZK-91587</span></li>
<li><span class="new">ZK-97894</span></li></ul>

<ul><li><i>Nonsteroidal:</i> <a href="Amlodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amlodipine" title="Amlodipine">Amlodipine</a></li>
<li>Apararenone</li>
<li>Benidipine</li>
<li><span class="new">BR-4628</span></li>
<li>Esaxerenone</li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li>Finerenone</li>
<li><span class="new">Miricorilant (CORT-118335)</span></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li><a href="Nimodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimodipine" title="Nimodipine">Nimodipine</a></li>
<li><a href="Nitrendipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li>
<li><span class="new">PF-03882845</span></li>
<li><span class="new">SM-368229</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Mineralocorticoids and antimineralocorticoids</dd>
<dd>Glucocorticoid receptor modulators</dd>
<dd>List of corticosteroids</dd></dl>
</div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Progesterone_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progesterone_receptor_modulators" style="font-size:114%;margin:0 4em">Progesterone receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> 3β-Dihydroprogesterone</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>6α-Methylprogesterone</li>
<li>9α-Bromo-11-ketoprogesterone</li>
<li>11-Dehydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone</a></li>
<li>16α-Hydroxyprogesterone</li>
<li><span class="new">17α-Methyl-11-deoxycorticosterone acetate</span></li>
<li>20α-Dihydroprogesterone</li>
<li>20β-Dihydroprogesterone</li>
<li>Dimepregnen</li>
<li><a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">Diosgenin</a></li>
<li>P1-185</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Progesterone 3-acetyl enol ether</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> 20α-Dihydrodydrogesterone</li>
<li>20α-Dihydrotrengestone</li>
<li>DU-41164</li>
<li>DU-41165</li>
<li><a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Retroprogesterone</li>
<li>Ro 6-3129</li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Substituted progesterone derivatives:</i> 6α-Methyl-17α-bromoprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>16-Methylene-17α-hydroxyprogesterone acetate</li>
<li>17α-Bromoprogesterone</li>
<li>17α-Hydroxyprogesterone (hydroxyprogesterone)</li>
<li>17α-Methylprogesterone</li>
<li>Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone</li>
<li>Algestone acetonide</li>
<li>Algestone acetophenide</li>
<li>Anagestone</li>
<li>Anagestone acetate</li>
<li><span class="new">Bromethenmadinone</span></li>
<li>Bromethenmadinone acetate</li>
<li>Butagest (buterol)</li>
<li>Chlormadinone</li>
<li>Chlormadinone acetate</li>
<li>Chlormadinone caproate</li>
<li><span class="new">Chlormethenmadinone</span></li>
<li>Chlormethenmadinone acetate</li>
<li>Cismadinone</li>
<li>Cismadinone acetate</li>
<li>Clogestone</li>
<li>Clogestone acetate</li>
<li>Clomegestone</li>
<li>Clomegestone acetate</li>
<li>Cymegesolate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone</li>
<li>Delmadinone acetate</li>
<li>Edogestrone</li>
<li>Flugestone</li>
<li>Flugestone acetate</li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li>Fluorometholone acetate</li>
<li>Flumedroxone</li>
<li>Flumedroxone acetate</li>
<li>Fluoromedroxyprogesterone acetate</li>
<li>Gestaclone</li>
<li>Haloprogesterone</li>
<li>Hydromadinone</li>
<li>Hydromadinone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)</li>
<li>Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)</li>
<li>Hydroxyprogesterone heptanoate benzilic acid hydrazone</li>
<li>Mecigestone (pentarane B)</li>
<li>Medrogestone</li>
<li><a href="Medroxyprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone" title="Medroxyprogesterone">Medroxyprogesterone</a></li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Medroxyprogesterone caproate</li>
<li><a href="Megestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Megestrol" title="Megestrol">Megestrol</a></li>
<li>Megestrol acetate</li>
<li>Megestrol caproate</li>
<li>Melengestrol</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone</li>
<li>Methenmadinone acetate</li>
<li>Methenmadinone caproate</li>
<li>Mometasone</li>
<li><a href="Mometasone_furoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Mometasone_furoate" title="Mometasone furoate" class="mw-redirect">Mometasone furoate</a></li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Pentagestrone</li>
<li>Pentagestrone acetate</li>
<li>Pentarane A</li>
<li>Proligestone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> 17α-Methyl-19-norprogesterone</li>
<li>18-Methylsegesterone acetate</li>
<li>19-Norprogesterone</li>
<li>Amadinone</li>
<li>Amadinone acetate</li>
<li>Demegestone</li>
<li><span class="new">Fluoro ethyl norprogesterone</span></li>
<li><span class="new">Fluoro furanyl norprogesterone</span></li>
<li>Gestadienol</li>
<li>Gestadienol acetate</li>
<li>Gestonorone acetate (gestronol acetate)</li>
<li>Gestonorone caproate (gestronol hexanoate)</li>
<li>Gestronol (gestonorone)</li>
<li>Nomegestrol</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>ORG-2058</li>
<li>Oxogestone</li>
<li>Oxogestone phenpropionate (xinogestone)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Segesterone</li>
<li>Segesterone acetate (nestorone)</li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> Progestins: 6,6-Difluoronorethisterone</li>
<li>6,6-Difluoronorethisterone acetate</li>
<li>17α-Allyl-19-nortestosterone</li>
<li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Chloroethynylnorgestrel</li>
<li>Cingestol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li>Dienogest</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li>
<li>Ethynerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li>Metynodiol</li>
<li>Metynodiol diacetate</li>
<li>Norelgestromin</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol</li>
<li>Quingestanol acetate</li>
<li>Tibolone</li>
<li>Tigestol</li>
<li>Tosagestin; Anabolic–androgenic steroids: 11β-Methyl-19-nortestosterone</li>
<li>11β-Methyl-19-nortestosterone dodecylcarbonate</li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Bolandione</li>
<li>Dimethisterone</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone</li>
<li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol (ethylnandrol)</a></li>
<li>Methyldienolone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone (R-1881)</a></li>
<li>Methoxydienone (methoxygonadiene)</li>
<li>Mibolerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a></li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethandrolone, normethisterone)</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li>
<li>Trenbolone (trienolone)</li>
<li>Trenbolone esters (e.g., trenbolone acetate, trenbolone enanthate)</li>
<li>Trendione</li>
<li>Trestolone</li>
<li>Trestolone acetate</li></ul>

<ul><li><i>Spirolactone derivatives:</i> Canrenoic acid</li>
<li>Canrenone</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Mespirenone</li>
<li>Potassium canrenoate</li>
<li>Prorenone</li>
<li>SC-5233 (spirolactone)</li>
<li>SC-8109</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li></ul>

<ul><li><i>Nonsteroidal:</i> 3,8-Dihydrodiligustilide</li>
<li>LG-2527</li>
<li><span class="new">LG-100128</span></li>
<li>Riligustilide</li>
<li><span class="new">RWJ-26819</span></li>
<li><span class="new">RWJ-49853</span></li>
<li><span class="new">RWJ-60130</span></li>
<li>Tanaproget</li>
<li>ZM-182345</li></ul>

<ul><li><i>Unknown:</i> ORG-47241</li>
<li>ORG-201745</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SPRMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Dihydroethisterone</li>
<li>5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li>
<li>Asoprisnil</li>
<li>Asoprisnil ecamate</li>
<li>Guggulsterone</li>
<li><span class="new">J1042</span></li>
<li><span class="new">LG-120838</span></li>
<li>Metapristone (RU-42633)</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone (RU-486)</a></li>
<li><span class="new">ORF-9371</span></li>
<li>ORF-9326</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RMI-12936</span></li>
<li>Telapristone</li>
<li>Ulipristal acetate</li>
<li>Vilaprisan</li>
<li><span class="new">ZK-137316</span></li></ul>

<ul><li><i>Nonsteroidal:</i> <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">Kaempferol</a></li>
<li><span class="new">LG-120920</span></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li><span class="new">PRA-910</span></li>
<li><a href="Syringic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Syringic_acid" title="Syringic acid">Syringic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Aglepristone</li>
<li>Lilopristone</li>
<li>Lonaprisan</li>
<li>Onapristone</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-31806</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RTI 3021–022</span></li>
<li>Toripristone</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> Darolutamide</li>
<li><span class="new">LG-001447</span></li>
<li><span class="new">LG-100127</span></li>
<li><span class="new">LG-100128</span></li>
<li><span class="new">LG-120830</span></li>
<li><span class="new">LG-121046</span></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><span class="new">ZM-150271</span></li>
<li><span class="new">ZM-172406</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>mPR</abbr><br>(<abbr>PAQR</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>5β-Dihydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycortisone (21-hydroxyprogesterone)</a></li>
<li>11-Deoxycortisol (17α,21-dihydroxyprogesterone)</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Estrogen receptor modulators</dd>
<dd>List of progestogens</dd></dl>
</div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>